SLC9A9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.30361152878199
p value: 1.58318587125239E-4
refers to: SLC9A9

CLGN
type: EnsemblDatabaseReference

RBBP8P1
type: EnsemblDatabaseReference

GRIN2D DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.10943072959917
p value: 9.75132550122259E-46
refers to: GRIN2D

FAM71E1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.0395228849674
p value: 0.0416074540499901
refers to: FAM71E1

NDUFA4L2
type: EnsemblDatabaseReference

NID1
type: EnsemblDatabaseReference

STAMBPL1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.13614733376585
p value: 0.00195330585988857
refers to: STAMBPL1

SAMD9
type: EnsemblDatabaseReference

PNLDC1
type: EnsemblDatabaseReference

PDLIM1
type: EnsemblDatabaseReference

RP1-152L7.5
type: EnsemblDatabaseReference

GMPR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.56971301026574
p value: 0.00102158452129656
refers to: GMPR

ETNK2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.48359743729513
p value: 0.0101192113642836
refers to: ETNK2

CLEC2L
type: EnsemblDatabaseReference

DDX10P1
type: EnsemblDatabaseReference

CLEC2B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.42111655015422
p value: 0.0120686989097418
refers to: CLEC2B

MYEOV
type: EnsemblDatabaseReference

DNER
type: EnsemblDatabaseReference

PROSER2-AS1
type: EnsemblDatabaseReference

SAMD9
type: EnsemblDatabaseReference

NID1
type: EnsemblDatabaseReference

AXL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.78212385477315
p value: 2.71485699527136E-21
refers to: AXL

PLEKHG4
type: EnsemblDatabaseReference

DLX6
type: EnsemblDatabaseReference

TBC1D30 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.53990737554696
p value: 0.00627740706250913
refers to: TBC1D30

TSHZ3
type: EnsemblDatabaseReference

CRYBB1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.2671305147477
p value: 8.19970639134314E-4
refers to: CRYBB1

IGFBP5
type: EnsemblDatabaseReference

NCAM2
type: EnsemblDatabaseReference

CTA-250D10.23 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.39301224961025
p value: 5.51416599913137E-4
refers to: CTA-250D10.23

MEST
type: EnsemblDatabaseReference

IFITM3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.90894741686935
p value: 1.14738160888379E-37
refers to: IFITM3

AHRR
type: EnsemblDatabaseReference

EPB41L3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.18271710342507
p value: 1.14736245890803E-27
refers to: EPB41L3

RXFP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.04028245530942
p value: 4.38065986952951E-10
refers to: RXFP1

AL589743.1
type: EnsemblDatabaseReference

MIR210HG
type: EnsemblDatabaseReference

AC106875.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.20534506667438
p value: 5.92412818733201E-6
refers to: AC106875.1

PLEKHO1
type: EnsemblDatabaseReference

FJX1
type: EnsemblDatabaseReference

MYEOV
type: EnsemblDatabaseReference

DNER
type: EnsemblDatabaseReference

CHI3L1
type: EnsemblDatabaseReference

PROSER2-AS1
type: EnsemblDatabaseReference

KLHL6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.24090636997986
p value: 0.0478475079561648
refers to: KLHL6

CAMK2B
type: EnsemblDatabaseReference

RP11-452C13.1
type: EnsemblDatabaseReference

CCL2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.80109079153412
p value: 0.0477144636372853
refers to: CCL2

Analysis of 'azacytidine' vs 'untreated'
type: RNASeqDifferentialAnalysis

PLEKHG4
type: EnsemblDatabaseReference

TMEM139
type: EnsemblDatabaseReference

ADAP2
type: EnsemblDatabaseReference

PNMA5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 1.80553731756697E-59
refers to: PNMA5

DLX6
type: EnsemblDatabaseReference

KIF13A
type: EnsemblDatabaseReference

PLXNA2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.64989440655318
p value: 0.00110093307863313
refers to: PLXNA2

IGFBP5
type: EnsemblDatabaseReference

NCAM2
type: EnsemblDatabaseReference

KCP
type: EnsemblDatabaseReference

HMOX1
type: EnsemblDatabaseReference

NOD2
type: EnsemblDatabaseReference

AHRR
type: EnsemblDatabaseReference

MOSPD3
type: EnsemblDatabaseReference

EFNB2
type: EnsemblDatabaseReference

LANCL3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.37236638296068
p value: 4.90091166086415E-4
refers to: LANCL3

MOSPD3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.13513626702232
p value: 1.37814267309882E-29
refers to: MOSPD3

AL589743.1
type: EnsemblDatabaseReference

IFI27 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.35198802129112
p value: 2.72841622331949E-62
refers to: IFI27

MIR210HG
type: EnsemblDatabaseReference

RP11-51F16.1
type: EnsemblDatabaseReference

PLEKHO1
type: EnsemblDatabaseReference

LRRK2
type: EnsemblDatabaseReference

PLCB1
type: EnsemblDatabaseReference

CHI3L1
type: EnsemblDatabaseReference

RP4-647J21.1
type: EnsemblDatabaseReference

PRR5L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.7223776316614
p value: 5.10067412736839E-4
refers to: PRR5L

TGFBI
type: EnsemblDatabaseReference

LANCL3
type: EnsemblDatabaseReference

APP DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.48704708143657
p value: 0.00445376442240669
refers to: APP

RTN4RL1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 3.89698129559681
p value: 0.0409964101463337
refers to: RTN4RL1

MCMDC2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.32265619841509
p value: 0.0160861612063091
refers to: MCMDC2

ADAP2
type: EnsemblDatabaseReference

FBXO6
type: EnsemblDatabaseReference

RUFY4
type: EnsemblDatabaseReference

HMOX1
type: EnsemblDatabaseReference

SORT1
type: EnsemblDatabaseReference

C1orf228
type: EnsemblDatabaseReference

EFNB2
type: EnsemblDatabaseReference

PTGDS DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.48382701592352
p value: 6.34113603520162E-5
refers to: PTGDS

ADAM28
type: EnsemblDatabaseReference

RP11-51F16.1
type: EnsemblDatabaseReference

LRRK2
type: EnsemblDatabaseReference

PLCB1
type: EnsemblDatabaseReference

RP4-647J21.1
type: EnsemblDatabaseReference

S100A9
type: EnsemblDatabaseReference

GIMAP1
type: EnsemblDatabaseReference

LANCL3
type: EnsemblDatabaseReference

FBXO6
type: EnsemblDatabaseReference

PLA2G7 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.78954610455804
p value: 0.00102291021482971
refers to: PLA2G7

RUFY4
type: EnsemblDatabaseReference

RFTN1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.26626181530887
p value: 1.44971169523338E-13
refers to: RFTN1

C1orf228
type: EnsemblDatabaseReference

FEZ1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.37917143766161
p value: 1.27610864627674E-19
refers to: FEZ1

HLA-G
type: EnsemblDatabaseReference

RP11-284F21.9
type: EnsemblDatabaseReference

TBX15
type: EnsemblDatabaseReference

VWCE DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.54084784203944
p value: 0.00420659385125438
refers to: VWCE

IRF7
type: EnsemblDatabaseReference

C9orf116 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.50404209674539
p value: 0.0124970304374087
refers to: C9orf116

HSD3B7
type: EnsemblDatabaseReference

IFI27
type: EnsemblDatabaseReference

ADAM28 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.28517464029201
p value: 2.78037628987036E-18
refers to: ADAM28

POU3F2
type: EnsemblDatabaseReference

(Factor value) COMPOUND/untreated
type: EFO_0001461
property type: COMPOUND
property value: untreated

UCN2
type: EnsemblDatabaseReference

DNER DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.27194394242809
p value: 4.17543193228933E-13
refers to: DNER

LINC00958 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.19720424072941
p value: 1.88954273774693E-6
refers to: LINC00958

HLA-G
type: EnsemblDatabaseReference

PARP14
type: EnsemblDatabaseReference

CCDC146
type: EnsemblDatabaseReference

FGL2
type: EnsemblDatabaseReference

TBX15
type: EnsemblDatabaseReference

ENHO DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.57170825056615
p value: 2.84550898348666E-6
refers to: ENHO

KCNC3
type: EnsemblDatabaseReference

EPAS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.17283405935678
p value: 3.10324367226805E-22
refers to: EPAS1

IRF7
type: EnsemblDatabaseReference

NLRC4
type: EnsemblDatabaseReference

HSD3B7
type: EnsemblDatabaseReference

GMPR
type: EnsemblDatabaseReference

UCN2
type: EnsemblDatabaseReference

POU3F2
type: EnsemblDatabaseReference

FAM127C
type: EnsemblDatabaseReference

PTPRO
type: EnsemblDatabaseReference

ALPK3
type: EnsemblDatabaseReference

GPAT2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.74965926073206
p value: 2.07517154257359E-8
refers to: GPAT2

RLTPR
type: EnsemblDatabaseReference

OGDHL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.53769056637344
p value: 0.00420659385125438
refers to: OGDHL

MYO5C
type: EnsemblDatabaseReference

FGL2
type: EnsemblDatabaseReference

PARP14
type: EnsemblDatabaseReference

HCRTR2
type: EnsemblDatabaseReference

GAL UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.00377075618155
p value: 6.19869944141885E-9
refers to: GAL

EIF4E3
type: EnsemblDatabaseReference

PARP10 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.24439834848119
p value: 9.18520608638297E-23
refers to: PARP10

CPXM1
type: EnsemblDatabaseReference

KCNC3
type: EnsemblDatabaseReference

DLL1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.45691746290077
p value: 2.19700527839807E-10
refers to: DLL1

NLRC4
type: EnsemblDatabaseReference

RP11-124O11.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.56870825365415
p value: 0.0014315258381883
refers to: RP11-124O11.1

CD93 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -6.29734073679661
p value: 1.03883770311429E-12
refers to: CD93

(Assay) SRR1171526
type: Assay

SCAMP5
type: EnsemblDatabaseReference

DDX58
type: EnsemblDatabaseReference

TMEM25
type: EnsemblDatabaseReference

IL10RA
type: EnsemblDatabaseReference

RLTPR
type: EnsemblDatabaseReference

DLL1
type: EnsemblDatabaseReference

ARHGAP5
type: EnsemblDatabaseReference

DDX60L
type: EnsemblDatabaseReference

STAMBPL1
type: EnsemblDatabaseReference

MYO5C
type: EnsemblDatabaseReference

PTCH1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23863104219211
p value: 0.027770387300631
refers to: PTCH1

PPM1M
type: EnsemblDatabaseReference

RP11-533E19.5
type: EnsemblDatabaseReference

LYZ DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.65946169271404
p value: 0.0
refers to: LYZ

IFI35 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.3127140396287
p value: 2.55299189911558E-8
refers to: IFI35

RGCC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.12208165508058
p value: 0.0427320257777494
refers to: RGCC

CPLX1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 2.49050325133555
p value: 7.33671828598623E-14
refers to: CPLX1

LAMB2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 5.46059234455624E-10
refers to: LAMB2

OASL
type: EnsemblDatabaseReference

SCAMP5
type: EnsemblDatabaseReference

BCL6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.46288746924733
p value: 8.83816925927303E-25
refers to: BCL6

TMEM25
type: EnsemblDatabaseReference

IL10RA
type: EnsemblDatabaseReference

ADAMTS5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.27824916796182
p value: 1.79473161964436E-12
refers to: ADAMTS5

DDO
type: EnsemblDatabaseReference

COLGALT2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.71191838452457
p value: 0.0219817291006247
refers to: COLGALT2

ROBO1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.24054992017327
p value: 6.23166505078645E-5
refers to: ROBO1

LINC00886 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.09217247612011
p value: 4.90091166086415E-4
refers to: LINC00886

DLL1
type: EnsemblDatabaseReference

ARHGAP5
type: EnsemblDatabaseReference

DDX60L
type: EnsemblDatabaseReference

INHBA
type: EnsemblDatabaseReference

MIR600HG
type: EnsemblDatabaseReference

RP11-533E19.5
type: EnsemblDatabaseReference

LTBP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.51697345386439
p value: 0.0220221121433001
refers to: LTBP1

HIST1H2AC
type: EnsemblDatabaseReference

STAT1
type: EnsemblDatabaseReference

ZNF595
type: EnsemblDatabaseReference

COX8C
type: EnsemblDatabaseReference

PCLO
type: EnsemblDatabaseReference

RPS24P17 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.24611087593682
p value: 5.40962301659877E-7
refers to: RPS24P17

DDO
type: EnsemblDatabaseReference

TRIB2
type: EnsemblDatabaseReference

USP18
type: EnsemblDatabaseReference

MIR600HG
type: EnsemblDatabaseReference

PSMB8-AS1
type: EnsemblDatabaseReference

TDRD15
type: EnsemblDatabaseReference

CD163
type: EnsemblDatabaseReference

VCAN
type: EnsemblDatabaseReference

SGK1
type: EnsemblDatabaseReference

STAP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.01355015200646
p value: 1.24179537771812E-7
refers to: STAP1

(Factor value) COMPOUND/azacytidine
type: CHEBI 2038
property type: COMPOUND
property value: azacytidine

EMILIN1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.51441432021964
p value: 4.15612982634078E-23
refers to: EMILIN1

LPAR5
type: EnsemblDatabaseReference

C8orf31
type: EnsemblDatabaseReference

DLX6-AS1
type: EnsemblDatabaseReference

STAT1
type: EnsemblDatabaseReference

FKBP1B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.46448608532838
p value: 0.00255835382101858
refers to: FKBP1B

ICAM3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.28234055059479
p value: 2.79126648632292E-9
refers to: ICAM3

ULBP2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.06113900695614
p value: 0.00593411789081983
refers to: ULBP2

AF146191.4
type: EnsemblDatabaseReference

COX8C
type: EnsemblDatabaseReference

DDX60 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.67156788507366
p value: 5.16083181016956E-17
refers to: DDX60

CHST2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.05293096275618
p value: 1.76566676396376E-6
refers to: CHST2

TRPM4
type: EnsemblDatabaseReference

PCLO
type: EnsemblDatabaseReference

RGS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 1.88342240732877E-4
refers to: RGS1

NCF2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.26193246940207
p value: 0.001667400723051
refers to: NCF2

ANG
type: EnsemblDatabaseReference

USP18
type: EnsemblDatabaseReference

DLX5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.82097454342101
p value: 3.88223857160615E-5
refers to: DLX5

PTGER4
type: EnsemblDatabaseReference

HDHD3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.03385621889625
p value: 5.48348844031797E-5
refers to: HDHD3

PSMB8-AS1
type: EnsemblDatabaseReference

TDRD15
type: EnsemblDatabaseReference

CD163
type: EnsemblDatabaseReference

VCAN
type: EnsemblDatabaseReference

LINC01096
type: EnsemblDatabaseReference

RAB27B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.6575400242432
p value: 2.17076318183782E-4
refers to: RAB27B

SGK1
type: EnsemblDatabaseReference

PRDM1
type: EnsemblDatabaseReference

MMP13
type: EnsemblDatabaseReference

S100A12 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0131515952819408
refers to: S100A12

DLX6-AS1
type: EnsemblDatabaseReference

RAB27B
type: EnsemblDatabaseReference

LPAR5
type: EnsemblDatabaseReference

PFN2
type: EnsemblDatabaseReference

SLC6A14 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.03455694656995
p value: 7.2614260693669E-5
refers to: SLC6A14

SERINC2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.47683249877436
p value: 3.09213958711571E-5
refers to: SERINC2

S100P
type: EnsemblDatabaseReference

TNN
type: EnsemblDatabaseReference

C8orf31
type: EnsemblDatabaseReference

TRPM4
type: EnsemblDatabaseReference

PTAFR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.0762287868204
p value: 5.17846588394917E-10
refers to: PTAFR

TDRD9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.19043606925443
p value: 6.532893114511E-16
refers to: TDRD9

PRR5L
type: EnsemblDatabaseReference

SCAMP5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.17161253558376
p value: 4.30966585814843E-16
refers to: SCAMP5

AQP1
type: EnsemblDatabaseReference

HERC5
type: EnsemblDatabaseReference

CHRM4
type: EnsemblDatabaseReference

GEM DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.27205730157641
p value: 0.023119941253694
refers to: GEM

TYMP
type: EnsemblDatabaseReference

CXXC5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.59336645555955
p value: 5.21338729971901E-59
refers to: CXXC5

PDGFA DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.33609712124357
p value: 1.35334086710481E-9
refers to: PDGFA

CHST15 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.013871932190375
refers to: CHST15

ZNF595 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.11253569237603
p value: 1.30550598071222E-27
refers to: ZNF595

HIST1H3H
type: EnsemblDatabaseReference

PTGER4
type: EnsemblDatabaseReference

LINC01096
type: EnsemblDatabaseReference

MYCL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.18781282917932
p value: 3.21987886057137E-5
refers to: MYCL

RIN2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.84779107022479
p value: 8.87334006357473E-13
refers to: RIN2

MYO7A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.77412875413107
p value: 1.18815251450114E-7
refers to: MYO7A

GPR158
type: EnsemblDatabaseReference

EVA1B
type: EnsemblDatabaseReference

RP11-1220K2.2
type: EnsemblDatabaseReference

RP11-124O11.1
type: EnsemblDatabaseReference

STAT2
type: EnsemblDatabaseReference

STAT4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.21241495522958
p value: 0.00555662712677414
refers to: STAT4

MLLT3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.37417836747285
p value: 4.33591059362823E-7
refers to: MLLT3

AQP1
type: EnsemblDatabaseReference

TYMP
type: EnsemblDatabaseReference

NPAS1
type: EnsemblDatabaseReference

HIST1H3H
type: EnsemblDatabaseReference

CYB5R2
type: EnsemblDatabaseReference

EDIL3
type: EnsemblDatabaseReference

CD300A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23000631941742
p value: 6.65507306861763E-4
refers to: CD300A

SLC44A4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.09903515955016
p value: 2.89061114542642E-22
refers to: SLC44A4

GBP5
type: EnsemblDatabaseReference

EVA1B
type: EnsemblDatabaseReference

FCGR2B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.99423369673957
p value: 7.3321271400515E-40
refers to: FCGR2B

RP11-124O11.1
type: EnsemblDatabaseReference

STAT2
type: EnsemblDatabaseReference

HLA-DMB
type: EnsemblDatabaseReference

NPAS1
type: EnsemblDatabaseReference

DOC2B
type: EnsemblDatabaseReference

LTBP1
type: EnsemblDatabaseReference

MEIS2
type: EnsemblDatabaseReference

RP11-321E2.3 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 2.66398925424239
p value: 0.0367697337211627
refers to: RP11-321E2.3

CKM DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 6.12481443568967E-31
refers to: CKM

RP11-330A16.1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.56536244282095
p value: 4.70536581450223E-4
refers to: RP11-330A16.1

GBP5
type: EnsemblDatabaseReference

CLEC7A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.06132203414531
p value: 0.00736057921593776
refers to: CLEC7A

KRT8
type: EnsemblDatabaseReference

TNNC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.41812767400061
p value: 0.0467595668218089
refers to: TNNC1

RHPN2 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.11362375658193
p value: 1.11998057739216E-6
refers to: RHPN2

BAIAP3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.66580945210659
p value: 1.42175552125153E-7
refers to: BAIAP3

FYN DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.67283733783629
p value: 0.00174338301332148
refers to: FYN

GEM
type: EnsemblDatabaseReference

IL18BP DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.02583974027198
p value: 5.31081933732389E-4
refers to: IL18BP

CRIPAK
type: EnsemblDatabaseReference

B3GNT8
type: EnsemblDatabaseReference

LTBP1
type: EnsemblDatabaseReference

LPL
type: EnsemblDatabaseReference

NGFR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.97875175626963
p value: 8.20021398815166E-17
refers to: NGFR

PDGFA
type: EnsemblDatabaseReference

ETV7 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.85838474842012
p value: 0.022959005324676
refers to: ETV7

MAP7D2
type: EnsemblDatabaseReference

KRT8
type: EnsemblDatabaseReference

RP5-884M6.1
type: EnsemblDatabaseReference

GAS1
type: EnsemblDatabaseReference

HIST1H2BK DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.27188463774668
p value: 1.87728800573564E-8
refers to: HIST1H2BK

NFAM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.94030265935093
p value: 1.78224557863931E-27
refers to: NFAM1

RAB30 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.57913939493656
p value: 0.0465774802297965
refers to: RAB30

PI15
type: EnsemblDatabaseReference

IRF6
type: EnsemblDatabaseReference

B3GNT8
type: EnsemblDatabaseReference

PREX2
type: EnsemblDatabaseReference

CHST2
type: EnsemblDatabaseReference

CD109
type: EnsemblDatabaseReference

(Assay) SRR1171527
type: Assay

MMP25 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.22598362619023
p value: 1.34392134699069E-4
refers to: MMP25

CCL2
type: EnsemblDatabaseReference

PTGER4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.33441463463937
p value: 5.1055531658691E-31
refers to: PTGER4

LPL
type: EnsemblDatabaseReference

CD84 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.17861080566815
p value: 0.0050796971915588
refers to: CD84

PDGFA
type: EnsemblDatabaseReference

TRAF1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.39375001621986
p value: 4.9733985011505E-5
refers to: TRAF1

PPIC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.48632680991567
p value: 1.77011665998626E-7
refers to: PPIC

MAP7D2
type: EnsemblDatabaseReference

RIMS2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.29905102238665
p value: 0.0377201418101894
refers to: RIMS2

PLSCR1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.05780200556622
p value: 6.44263569864627E-21
refers to: PLSCR1

IRF6
type: EnsemblDatabaseReference

PARP9
type: EnsemblDatabaseReference

PREX2
type: EnsemblDatabaseReference

CHST2
type: EnsemblDatabaseReference

CD109
type: EnsemblDatabaseReference

CLU DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.455789123182
p value: 0.0411732781554985
refers to: CLU

DHX58
type: EnsemblDatabaseReference

MCMDC2
type: EnsemblDatabaseReference

FCGR2B
type: EnsemblDatabaseReference

NAPSB
type: EnsemblDatabaseReference

PRTG
type: EnsemblDatabaseReference

MKRN4P
type: EnsemblDatabaseReference

RYR1
type: EnsemblDatabaseReference

HSPB6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.68695179500437
p value: 1.12102915710036E-10
refers to: HSPB6

DDX60L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.15512305989015
p value: 1.5311012522837E-14
refers to: DDX60L

SNCA
type: EnsemblDatabaseReference

TMEM169 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.74026855217537
p value: 2.02116452028016E-4
refers to: TMEM169

PLEKHO1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.60148733732366
p value: 7.83308318971094E-30
refers to: PLEKHO1

DOC2B UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.25128812485794
p value: 0.0253356282748271
refers to: DOC2B

RP5-1157M23.2
type: EnsemblDatabaseReference

FSTL1
type: EnsemblDatabaseReference

MCMDC2
type: EnsemblDatabaseReference

PLXDC2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.85850206822509
p value: 8.54761372591172E-28
refers to: PLXDC2

NAPSB
type: EnsemblDatabaseReference

TAC4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.55743348624415
p value: 0.0302958443884384
refers to: TAC4

COLGALT2
type: EnsemblDatabaseReference

MKRN4P
type: EnsemblDatabaseReference

RYR1
type: EnsemblDatabaseReference

SNCA
type: EnsemblDatabaseReference

DLX2
type: EnsemblDatabaseReference

DACH1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.91952681491691
p value: 0.00111983119030824
refers to: DACH1

RCBTB2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.1328709563891
p value: 1.13026846842154E-14
refers to: RCBTB2

DAZL
type: EnsemblDatabaseReference

PSMB9
type: EnsemblDatabaseReference

FEZ1
type: EnsemblDatabaseReference

PCDH7 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.66835665291947
p value: 0.00200565149453531
refers to: PCDH7

TGFA
type: EnsemblDatabaseReference

HIST1H2BD DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.81773247563344
p value: 8.43646665906735E-8
refers to: HIST1H2BD

NFE2
type: EnsemblDatabaseReference

COL4A4
type: EnsemblDatabaseReference

RSAD2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.28628267246744
p value: 6.84276376150466E-24
refers to: RSAD2

ACRC
type: EnsemblDatabaseReference

SPHK1
type: EnsemblDatabaseReference

COLGALT2
type: EnsemblDatabaseReference

PNOC
type: EnsemblDatabaseReference

STAT5A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.896814835989
p value: 3.26349130077329E-9
refers to: STAT5A

DDO DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.71144521708052
p value: 0.00153304029602765
refers to: DDO

DLX2
type: EnsemblDatabaseReference

CDX2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.31590803089107
p value: 0.030343587572028
refers to: CDX2

DAZL
type: EnsemblDatabaseReference

PSMB9
type: EnsemblDatabaseReference

ARMCX4
type: EnsemblDatabaseReference

BANK1
type: EnsemblDatabaseReference

LPAR1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.49104677860663
p value: 7.55909655960977E-7
refers to: LPAR1

FEZ1
type: EnsemblDatabaseReference

GPR68 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.6263330500896
p value: 0.00121282363851964
refers to: GPR68

LPO DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.20708764859438
p value: 2.26390842078729E-7
refers to: LPO

SPHK1
type: EnsemblDatabaseReference

CTA-250D10.23
type: EnsemblDatabaseReference

COL4A4
type: EnsemblDatabaseReference

LINC00639
type: EnsemblDatabaseReference

SP110 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.12607907886572
p value: 1.18700981353322E-20
refers to: SP110

ACRC
type: EnsemblDatabaseReference

AIM2
type: EnsemblDatabaseReference

SERPINI1
type: EnsemblDatabaseReference

SPINT1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.09621078149188
p value: 5.9461763972456E-13
refers to: SPINT1

ECHDC2
type: EnsemblDatabaseReference

PNOC
type: EnsemblDatabaseReference

ID2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23917340794255
p value: 7.72292004618784E-18
refers to: ID2

PRDM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23052644588451
p value: 5.39141052505479E-5
refers to: PRDM1

ARHGAP20 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.8322430024787
p value: 0.00159179989306295
refers to: ARHGAP20

PDGFC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.37426363457151
p value: 7.30453758125594E-8
refers to: PDGFC

XKR9
type: EnsemblDatabaseReference

IFITM1
type: EnsemblDatabaseReference

ARMCX4
type: EnsemblDatabaseReference

BANK1
type: EnsemblDatabaseReference

DIRAS3
type: EnsemblDatabaseReference

LINC01021 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.66247922250732
p value: 1.59279263385557E-4
refers to: LINC01021

CTA-250D10.23
type: EnsemblDatabaseReference

VAT1L
type: EnsemblDatabaseReference

ADAP2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.16443033301254
p value: 0.0246769730848654
refers to: ADAP2

MMP12
type: EnsemblDatabaseReference

RP3-325F22.5 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.88967112079416
p value: 0.0458916802836599
refers to: RP3-325F22.5

GAS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.32363463780752
p value: 0.00588033695123215
refers to: GAS1

PCLO DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.57913938695305
p value: 7.0451969822496E-4
refers to: PCLO

PTGS2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.0363183372149
p value: 5.67044792256049E-7
refers to: PTGS2

SLC39A4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.31832765766068
p value: 4.59797595872089E-37
refers to: SLC39A4

EPSTI1
type: EnsemblDatabaseReference

IL4I1
type: EnsemblDatabaseReference

CSF1
type: EnsemblDatabaseReference

PREX2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.09268599327343
p value: 1.1078643306957E-8
refers to: PREX2

HORMAD1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -6.62996401205098
p value: 2.27890575590568E-13
refers to: HORMAD1

XKR9
type: EnsemblDatabaseReference

IFITM1
type: EnsemblDatabaseReference

AC093673.5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.0507875035905
p value: 9.48009143489378E-6
refers to: AC093673.5

DIRAS3
type: EnsemblDatabaseReference

PARP12
type: EnsemblDatabaseReference

AIM2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.30599697751637
p value: 0.00526257559087924
refers to: AIM2

AC106875.1
type: EnsemblDatabaseReference

PTPN13
type: EnsemblDatabaseReference

VAT1L
type: EnsemblDatabaseReference

EOMES DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.62915693636924
p value: 5.34091168765385E-10
refers to: EOMES

GABRE
type: EnsemblDatabaseReference

MEIS2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.12132515388415
p value: 1.39355025988348E-5
refers to: MEIS2

UNC5B
type: EnsemblDatabaseReference

EMR1
type: EnsemblDatabaseReference

MMP12
type: EnsemblDatabaseReference

EPSTI1
type: EnsemblDatabaseReference

IL4I1
type: EnsemblDatabaseReference

SYCE2
type: EnsemblDatabaseReference

AF146191.4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.5465412617708
p value: 0.0468891647729878
refers to: AF146191.4

TRAF5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10440420661542
p value: 4.80923243593005E-4
refers to: TRAF5

CSF1
type: EnsemblDatabaseReference

RBBP8P1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0407533463242268
refers to: RBBP8P1

HSPA7
type: EnsemblDatabaseReference

SFRP2
type: EnsemblDatabaseReference

FCER2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.48304945315545
p value: 0.0359978815838965
refers to: FCER2

SAMD9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.00910580569475
p value: 2.99967146903451E-6
refers to: SAMD9

WNT5B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.39820631960272
p value: 1.46024452211991E-5
refers to: WNT5B

GALNT12
type: EnsemblDatabaseReference

LGALS9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.32440677660941
p value: 3.2679078361981E-56
refers to: LGALS9

HIST1H4I DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.60462825594492
p value: 7.26685786121384E-11
refers to: HIST1H4I

GABRE
type: EnsemblDatabaseReference

LBH DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.58412976511756
p value: 0.00754286885873335
refers to: LBH

YPEL3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.06203171510615
p value: 4.53889531093419E-11
refers to: YPEL3

WFS1
type: EnsemblDatabaseReference

LINC01021
type: EnsemblDatabaseReference

EMR1
type: EnsemblDatabaseReference

FAM198B
type: EnsemblDatabaseReference

CLGN DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.27955331763951
p value: 6.62123896885034E-5
refers to: CLGN

ARHGAP5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.60184204540852
p value: 7.21744174415015E-7
refers to: ARHGAP5

FGL2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.49402462284308
p value: 1.20239817351058E-13
refers to: FGL2

B3GALT4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.33203338277155
p value: 0.0113855754276705
refers to: B3GALT4

SYCE2
type: EnsemblDatabaseReference

ATF5
type: EnsemblDatabaseReference

LL0XNC01-16G2.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0292409164820956
refers to: LL0XNC01-16G2.1

HSPA7
type: EnsemblDatabaseReference

SFRP2
type: EnsemblDatabaseReference

DLX6-AS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.72041645951764
p value: 2.77832305353941E-4
refers to: DLX6-AS1

ZNF205
type: EnsemblDatabaseReference

CYTIP DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.19959618933544
p value: 1.23992115709497E-8
refers to: CYTIP

TRIM69
type: EnsemblDatabaseReference

B3GALT4
type: EnsemblDatabaseReference

GALNT12
type: EnsemblDatabaseReference

UNC5CL
type: EnsemblDatabaseReference

ZNF467
type: EnsemblDatabaseReference

OAS3
type: EnsemblDatabaseReference

LINC01021
type: EnsemblDatabaseReference

LINC00200
type: EnsemblDatabaseReference

ATF5
type: EnsemblDatabaseReference

ETNK2
type: EnsemblDatabaseReference

CCNA1
type: EnsemblDatabaseReference

PARD6A
type: EnsemblDatabaseReference

RUFY4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.5311123435529
p value: 0.0442945596755565
refers to: RUFY4

ST14
type: EnsemblDatabaseReference

LBH
type: EnsemblDatabaseReference

USP18 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.32235068916937
p value: 4.80154842554914E-16
refers to: USP18

TRIM69
type: EnsemblDatabaseReference

B3GALT4
type: EnsemblDatabaseReference

UNC5CL
type: EnsemblDatabaseReference

ZNF467
type: EnsemblDatabaseReference

OAS3
type: EnsemblDatabaseReference

PPM1E
type: EnsemblDatabaseReference

CD209 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.45529283348932
p value: 1.26673164841007E-12
refers to: CD209

IL18BP
type: EnsemblDatabaseReference

LINC01296
type: EnsemblDatabaseReference

STRA6 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.84777280015469
p value: 0.0158070748194836
refers to: STRA6

LRRC18
type: EnsemblDatabaseReference

CLEC5A
type: EnsemblDatabaseReference

FAM46A
type: EnsemblDatabaseReference

EPSTI1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.32588160757063
p value: 4.65893283510724E-31
refers to: EPSTI1

LRRK2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.421864576432
p value: 4.63233111123876E-8
refers to: LRRK2

LGALS9
type: EnsemblDatabaseReference

ETNK2
type: EnsemblDatabaseReference

CCNA1
type: EnsemblDatabaseReference

PARD6A
type: EnsemblDatabaseReference

PRICKLE2
type: EnsemblDatabaseReference

ST14
type: EnsemblDatabaseReference

KCP DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.47633761843839
p value: 0.00214144995447777
refers to: KCP

TBX3
type: EnsemblDatabaseReference

CALD1
type: EnsemblDatabaseReference

STAT4
type: EnsemblDatabaseReference

PPM1E
type: EnsemblDatabaseReference

PDGFC
type: EnsemblDatabaseReference

LY86
type: EnsemblDatabaseReference

IFIT3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.96743902640582
p value: 4.51210696566997E-61
refers to: IFIT3

PRTG UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.05661132529827
p value: 8.4972987714706E-6
refers to: PRTG

FCGR2C
type: EnsemblDatabaseReference

FAM46A
type: EnsemblDatabaseReference

LGALS9
type: EnsemblDatabaseReference

APP
type: EnsemblDatabaseReference

PDLIM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.72264891513614
p value: 0.00390778610796855
refers to: PDLIM1

RP1-234P15.4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.12031210834252
p value: 0.0418811715636983
refers to: RP1-234P15.4

RP1-152L7.5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.82483548989872
p value: 0.0020171008461147
refers to: RP1-152L7.5

FUCA1
type: EnsemblDatabaseReference

MESP1
type: EnsemblDatabaseReference

SERPINB10
type: EnsemblDatabaseReference

PDGFC
type: EnsemblDatabaseReference

LY86
type: EnsemblDatabaseReference

U82695.5
type: EnsemblDatabaseReference

CCDC152
type: EnsemblDatabaseReference

APP
type: EnsemblDatabaseReference

LGALS3BP
type: EnsemblDatabaseReference

S100A8
type: EnsemblDatabaseReference

PTGDS
type: EnsemblDatabaseReference

ANK3
type: EnsemblDatabaseReference

DOCK4
type: EnsemblDatabaseReference

ANO9
type: EnsemblDatabaseReference

SAMSN1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.70788901502787
p value: 0.00583635209356378
refers to: SAMSN1

RASGEF1A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.82847631949858
p value: 0.0141644876218588
refers to: RASGEF1A

RP11-51F16.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.82875731439729
p value: 5.63774163920435E-4
refers to: RP11-51F16.1

CCDC152
type: EnsemblDatabaseReference

GLI3
type: EnsemblDatabaseReference

RCBTB2
type: EnsemblDatabaseReference

PCED1B
type: EnsemblDatabaseReference

MYO5C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.39521040798202
p value: 8.91956312585001E-13
refers to: MYO5C

CDX2
type: EnsemblDatabaseReference

S100A8
type: EnsemblDatabaseReference

MAGEC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.00175470845112173
refers to: MAGEC1

IFIH1
type: EnsemblDatabaseReference

DOCK4
type: EnsemblDatabaseReference

IFIT2
type: EnsemblDatabaseReference

ANO9
type: EnsemblDatabaseReference

LPAR6
type: EnsemblDatabaseReference

TRAF1
type: EnsemblDatabaseReference

SULF2
type: EnsemblDatabaseReference

PARP12 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.76471284325124
p value: 4.07471164944565E-23
refers to: PARP12

KIF17
type: EnsemblDatabaseReference

RAB30
type: EnsemblDatabaseReference

HSPA1A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.62265588864868
p value: 0.0122373815600431
refers to: HSPA1A

COL9A2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.79209042827287
p value: 3.61147860766858E-11
refers to: COL9A2

PHLDB3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.82155241336589
p value: 0.00198477045774903
refers to: PHLDB3

RP11-497G19.2
type: EnsemblDatabaseReference

ANXA1
type: EnsemblDatabaseReference

JAK3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.13175324584584
p value: 2.26869999521349E-6
refers to: JAK3

STEAP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.07690098795096
p value: 0.0124771652143922
refers to: STEAP1

CFH
type: EnsemblDatabaseReference

RP11-1112C15.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.15343638062407
p value: 0.0115779393466178
refers to: RP11-1112C15.1

MYCL
type: EnsemblDatabaseReference

IFIH1
type: EnsemblDatabaseReference

MX1
type: EnsemblDatabaseReference

ACSS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.46830811316178
p value: 1.22198547678581E-4
refers to: ACSS1

HIST1H2BK
type: EnsemblDatabaseReference

IFIT2
type: EnsemblDatabaseReference

EIF2AK2
type: EnsemblDatabaseReference

DPY19L2P1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.19184079317908
p value: 0.0446037660415446
refers to: DPY19L2P1

MAPK6PS4
type: EnsemblDatabaseReference

LPAR6
type: EnsemblDatabaseReference

PCDH7
type: EnsemblDatabaseReference

OGDHL
type: EnsemblDatabaseReference

STK31
type: EnsemblDatabaseReference

AXL
type: EnsemblDatabaseReference

SULF2
type: EnsemblDatabaseReference

RP11-47A8.5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10838134473488
p value: 0.0070494671318668
refers to: RP11-47A8.5

KIF17
type: EnsemblDatabaseReference

RP1-234P15.4
type: EnsemblDatabaseReference

CLEC12A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.08872172350004
p value: 2.79163397060378E-7
refers to: CLEC12A

PCDH18
type: EnsemblDatabaseReference

MMP15 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.93151877899416
p value: 8.8888095008784E-10
refers to: MMP15

PRR16 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.56130168026907
p value: 6.07352572449815E-5
refers to: PRR16

PLK2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.69753637478136
p value: 9.30584651897618E-10
refers to: PLK2

FGR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.95347794803003
p value: 6.76565631876989E-12
refers to: FGR

MX1
type: EnsemblDatabaseReference

CABLES1
type: EnsemblDatabaseReference

MYCL
type: EnsemblDatabaseReference

DNAH8 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 2.01153575116261E-6
refers to: DNAH8

CLEC7A
type: EnsemblDatabaseReference

GPNMB
type: EnsemblDatabaseReference

HIST1H2BK
type: EnsemblDatabaseReference

NRG1
type: EnsemblDatabaseReference

EIF2AK2
type: EnsemblDatabaseReference

CDKN2B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.64507543358398
p value: 3.29501308882445E-4
refers to: CDKN2B

PCDH7
type: EnsemblDatabaseReference

OGDHL
type: EnsemblDatabaseReference

VCAN DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.09632645519611
p value: 5.69746855698356E-14
refers to: VCAN

STK31
type: EnsemblDatabaseReference

(Assay) SRR1171528
type: Assay

CHST15
type: EnsemblDatabaseReference

LTBP3
type: EnsemblDatabaseReference

SLC2A6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.12160500128487
p value: 1.68983170714157E-5
refers to: SLC2A6

RP1-234P15.4
type: EnsemblDatabaseReference

CTD-2184D3.5
type: EnsemblDatabaseReference

SLC27A3
type: EnsemblDatabaseReference

PCDH18
type: EnsemblDatabaseReference

VWA1
type: EnsemblDatabaseReference

SERINC2
type: EnsemblDatabaseReference

ANPEP
type: EnsemblDatabaseReference

LPO
type: EnsemblDatabaseReference

GSN DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.06487740575012
p value: 5.25857282261762E-21
refers to: GSN

GPR114
type: EnsemblDatabaseReference

EMILIN1
type: EnsemblDatabaseReference

(Sample) cell line/AML3
type: EFO_0000001
property type: cell line
property value: AML3

SPINT1
type: EnsemblDatabaseReference

CLEC7A
type: EnsemblDatabaseReference

NRG1
type: EnsemblDatabaseReference

SLC9A5
type: EnsemblDatabaseReference

SLC2A6
type: EnsemblDatabaseReference

EPHA3
type: EnsemblDatabaseReference

ARMCX4 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.03957244757796
p value: 8.42203419319596E-5
refers to: ARMCX4

CHST15
type: EnsemblDatabaseReference

LTBP3
type: EnsemblDatabaseReference

CORO2A
type: EnsemblDatabaseReference

SYTL1
type: EnsemblDatabaseReference

SLC27A3
type: EnsemblDatabaseReference

SSH3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.51693788789187
p value: 1.05053426860955E-8
refers to: SSH3

SERINC2
type: EnsemblDatabaseReference

GPR114
type: EnsemblDatabaseReference

SPP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.06309713078382
p value: 1.87335965164535E-4
refers to: SPP1

CHRM4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.30750895900956
p value: 0.00264003839581603
refers to: CHRM4

TSPAN2
type: EnsemblDatabaseReference

SLC2A6
type: EnsemblDatabaseReference

ARID5B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.55547110876231
p value: 3.72178096558987E-6
refers to: ARID5B

FJX1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.27385404778289
p value: 0.00919547438860526
refers to: FJX1

IL16
type: EnsemblDatabaseReference

(Assay) SRR1171525
type: Assay

HSPA6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.50694204900333
p value: 2.27866178336352E-4
refers to: HSPA6

CDK18
type: EnsemblDatabaseReference

SYTL1
type: EnsemblDatabaseReference

SIGLEC1
type: EnsemblDatabaseReference

PDZRN3
type: EnsemblDatabaseReference

OAS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.18479298672614
p value: 2.02454838734894E-27
refers to: OAS1

(Assay) SRR1171524
type: Assay

IL16
type: EnsemblDatabaseReference

STAT2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.25439987682953
p value: 3.07361779385898E-13
refers to: STAT2

CDK18
type: EnsemblDatabaseReference

TUBA4A
type: EnsemblDatabaseReference

EPB41L3
type: EnsemblDatabaseReference

DTX4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.45829953900684
p value: 3.5971707653979E-41
refers to: DTX4

FAM50B
type: EnsemblDatabaseReference

LINC01140 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.72510295407689
p value: 0.0115222020106286
refers to: LINC01140

FCGR2C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.69771509853207
p value: 0.016407599243473
refers to: FCGR2C

BCL6
type: EnsemblDatabaseReference

CRIPAK UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.02083481423771
p value: 2.45738187824474E-7
refers to: CRIPAK

CREB5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 3.86386424857534E-4
refers to: CREB5

FERMT2
type: EnsemblDatabaseReference

TRIM69 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.40597599997334
p value: 5.68227935065314E-9
refers to: TRIM69

STEAP1
type: EnsemblDatabaseReference

RP11-320G10.1
type: EnsemblDatabaseReference

STC1
type: EnsemblDatabaseReference

TUBA4A
type: EnsemblDatabaseReference

EPB41L3
type: EnsemblDatabaseReference

FAM50B
type: EnsemblDatabaseReference

MIR4674HG DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.07060375124214
p value: 0.0305122863107326
refers to: MIR4674HG

C19orf38
type: EnsemblDatabaseReference

BCL6
type: EnsemblDatabaseReference

LL22NC03-N14H11.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.13170742232555
p value: 0.00220847706406088
refers to: LL22NC03-N14H11.1

LAMB2
type: EnsemblDatabaseReference

DLX6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.57955659489023
p value: 0.0390698707776014
refers to: DLX6

AC011625.1
type: EnsemblDatabaseReference

GALNT12 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.71836980175121
p value: 1.11576866949914E-17
refers to: GALNT12

FAM115C
type: EnsemblDatabaseReference

RP11-320G10.1
type: EnsemblDatabaseReference

ANG DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.00335873072321
p value: 0.00354370312499349
refers to: ANG

STC1
type: EnsemblDatabaseReference

IER5L
type: EnsemblDatabaseReference

FLNC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.03507889136727
p value: 0.0240287060354294
refers to: FLNC

RP3-325F22.5
type: EnsemblDatabaseReference

FCER2
type: EnsemblDatabaseReference

ARID5B
type: EnsemblDatabaseReference

LAMB2
type: EnsemblDatabaseReference

CNRIP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.22093382431371
p value: 5.89970473849674E-10
refers to: CNRIP1

FAM13A
type: EnsemblDatabaseReference

FGFR1
type: EnsemblDatabaseReference

COL14A1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.27862615347476
p value: 7.29065738759057E-6
refers to: COL14A1

SVEP1
type: EnsemblDatabaseReference

CTD-2184D3.5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.02592642155896
p value: 2.17789691317715E-8
refers to: CTD-2184D3.5

RP11-863P13.4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.24643772459707
p value: 0.0278628186347765
refers to: RP11-863P13.4

LGALS3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.32524889274487
p value: 5.55591799718774E-8
refers to: LGALS3

RP3-395M20.8 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.00420123972259
p value: 0.0141951245830003
refers to: RP3-395M20.8

DNASE2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.9289776971098
p value: 2.7415360402161E-17
refers to: DNASE2

CTHRC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.73350852266743
p value: 1.33145867044063E-5
refers to: CTHRC1

AC011625.1
type: EnsemblDatabaseReference

FAM115C
type: EnsemblDatabaseReference

IER5L
type: EnsemblDatabaseReference

IGFBP3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.00983437472583
p value: 5.71809623783591E-58
refers to: IGFBP3

GBP2
type: EnsemblDatabaseReference

LY86 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.09664664695455
p value: 1.45612204414508E-28
refers to: LY86

FCER2
type: EnsemblDatabaseReference

RIN3
type: EnsemblDatabaseReference

HSD11B1
type: EnsemblDatabaseReference

IGFLR1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.17287858647752
p value: 0.00297287654133098
refers to: IGFLR1

SLC6A14
type: EnsemblDatabaseReference

FGR
type: EnsemblDatabaseReference

FGFR1
type: EnsemblDatabaseReference

LEKR1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.83220906000825
p value: 0.00568042152680106
refers to: LEKR1

KIF17 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.79653501682435
p value: 8.02961655839752E-10
refers to: KIF17

DIRAS3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.73897302559723
p value: 1.2378069602197E-4
refers to: DIRAS3

BARX1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.19954250995603
p value: 1.41596408648935E-8
refers to: BARX1

SP110
type: EnsemblDatabaseReference

GBP2
type: EnsemblDatabaseReference

EIF4E3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.03050738815538
p value: 0.00906300075112402
refers to: EIF4E3

HSH2D
type: EnsemblDatabaseReference

GABRE DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.69778122766202
p value: 0.00555627939747452
refers to: GABRE

RIN3
type: EnsemblDatabaseReference

MESP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.1753868103496
p value: 0.0360273656204028
refers to: MESP1

CDK18 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.11121390701379
p value: 3.04398922090977E-17
refers to: CDK18

HSD11B1
type: EnsemblDatabaseReference

PSMB8-AS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.24257972056446
p value: 2.34551842950459E-18
refers to: PSMB8-AS1

SLC6A14
type: EnsemblDatabaseReference

LY96 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.3257931128065
p value: 0.00334814719063664
refers to: LY96

ACSS1
type: EnsemblDatabaseReference

CACNA1A
type: EnsemblDatabaseReference

TMEM139 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 2.18282427969059
p value: 0.0104348349453487
refers to: TMEM139

RIMS2
type: EnsemblDatabaseReference

HIST1H2BD
type: EnsemblDatabaseReference

IFIH1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.55371405192971
p value: 1.1684342250621E-13
refers to: IFIH1

SNX20
type: EnsemblDatabaseReference

HSH2D
type: EnsemblDatabaseReference

ABHD4
type: EnsemblDatabaseReference

ATF5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.29006857887528
p value: 4.33130808036535E-51
refers to: ATF5

NR5A1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.55748623200506
p value: 2.73135579976855E-8
refers to: NR5A1

RP4-781K5.6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.85367004520513
p value: 0.0108545975347364
refers to: RP4-781K5.6

MEIOB
type: EnsemblDatabaseReference

ACSS1
type: EnsemblDatabaseReference

CACNA1A
type: EnsemblDatabaseReference

RIMS2
type: EnsemblDatabaseReference

HIST1H2BD
type: EnsemblDatabaseReference

CD109 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.08875605780758
p value: 5.78491905320698E-13
refers to: CD109

CES1P1
type: EnsemblDatabaseReference

ABHD4
type: EnsemblDatabaseReference

SPARC
type: EnsemblDatabaseReference

TLR6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.12209996082823
p value: 3.93003879705749E-6
refers to: TLR6

SERPINB2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.60195027038064
p value: 0.00257929596570664
refers to: SERPINB2

C19orf38 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.71059957100247
p value: 0.00296522786204405
refers to: C19orf38

CDH10
type: EnsemblDatabaseReference

CHRNE
type: EnsemblDatabaseReference

MEIOB
type: EnsemblDatabaseReference

AIM1
type: EnsemblDatabaseReference

S100A12
type: EnsemblDatabaseReference

APBA1
type: EnsemblDatabaseReference

SYTL1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.43553078132084
p value: 1.22841248206895E-4
refers to: SYTL1

HERC6
type: EnsemblDatabaseReference

RP11-61L23.2
type: EnsemblDatabaseReference

EEF1A2
type: EnsemblDatabaseReference

AC110781.3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.38485938003108
p value: 0.0368524817831339
refers to: AC110781.3

IFIT5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.92568342469911
p value: 5.21629864126291E-13
refers to: IFIT5

SPARC
type: EnsemblDatabaseReference

HIST2H2BE DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.67291879903537
p value: 2.34861861722619E-5
refers to: HIST2H2BE

AIM1
type: EnsemblDatabaseReference

SLC5A9
type: EnsemblDatabaseReference

RP11-61L23.2
type: EnsemblDatabaseReference

C6orf223 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 1.18399578487588E-6
refers to: C6orf223

IFIT2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.10941073636671
p value: 8.12123431020659E-24
refers to: IFIT2

MAOB
type: EnsemblDatabaseReference

MFAP2
type: EnsemblDatabaseReference

CD226 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.66019896680494
p value: 1.64885376050353E-8
refers to: CD226

ISG20 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.58647719632366
p value: 9.49767724187636E-4
refers to: ISG20

EEF1A2
type: EnsemblDatabaseReference

GIMAP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.00590787383051
p value: 0.0277264920251155
refers to: GIMAP1

FILIP1L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.21961465899043
p value: 2.95714405331154E-13
refers to: FILIP1L

DMD DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.65217625712279
p value: 0.0199785524358225
refers to: DMD

RBP4
type: EnsemblDatabaseReference

LL22NC03-N14H11.1
type: EnsemblDatabaseReference

STAB1
type: EnsemblDatabaseReference

GNG11
type: EnsemblDatabaseReference

CD244 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.14171386429401
p value: 6.37954383373599E-22
refers to: CD244

LL0XNC01-16G2.1
type: EnsemblDatabaseReference

PFN2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.84627736900844
p value: 1.7991186987226E-11
refers to: PFN2

HLA-B
type: EnsemblDatabaseReference

SLC5A9
type: EnsemblDatabaseReference

ATP6V0E2-AS1
type: EnsemblDatabaseReference

PARP9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.65174964332309
p value: 1.54809610319852E-42
refers to: PARP9

RP11-863P13.4
type: EnsemblDatabaseReference

ZNF501
type: EnsemblDatabaseReference

MFAP2
type: EnsemblDatabaseReference

MAOB
type: EnsemblDatabaseReference

RP11-10A14.5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.45477866417193
p value: 1.4743793686075E-6
refers to: RP11-10A14.5

RP11-497G19.1
type: EnsemblDatabaseReference

OAS2
type: EnsemblDatabaseReference

GPAT2
type: EnsemblDatabaseReference

IFI44
type: EnsemblDatabaseReference

RP11-36D19.9
type: EnsemblDatabaseReference

TNN DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.53763463935738
p value: 5.58111054246063E-16
refers to: TNN

RASGEF1A
type: EnsemblDatabaseReference

MYO7A
type: EnsemblDatabaseReference

HSPB6
type: EnsemblDatabaseReference

STAB1
type: EnsemblDatabaseReference

CD244
type: EnsemblDatabaseReference

GNG11
type: EnsemblDatabaseReference

C8orf31 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.22518882985722
p value: 0.0127915534013111
refers to: C8orf31

LL0XNC01-16G2.1
type: EnsemblDatabaseReference

CPXM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.86157820398139
p value: 1.17915211187573E-106
refers to: CPXM1

HLA-B
type: EnsemblDatabaseReference

S100A9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.83536276528582
p value: 5.19578386890055E-35
refers to: S100A9

PCOLCE
type: EnsemblDatabaseReference

ATP6V0E2-AS1
type: EnsemblDatabaseReference

LGALS3
type: EnsemblDatabaseReference

RP11-863P13.4
type: EnsemblDatabaseReference

IRF7 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.58853359336347
p value: 3.09824375611564E-15
refers to: IRF7

RPS24P17
type: EnsemblDatabaseReference

ZNF501
type: EnsemblDatabaseReference

AC006116.20
type: EnsemblDatabaseReference

RIPK3
type: EnsemblDatabaseReference

IFI44L
type: EnsemblDatabaseReference

OAS2
type: EnsemblDatabaseReference

GPAT2
type: EnsemblDatabaseReference

RP11-533E19.5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.29573514504713
p value: 0.0240287060354294
refers to: RP11-533E19.5

GBP1
type: EnsemblDatabaseReference

TBC1D30
type: EnsemblDatabaseReference

RASGEF1A
type: EnsemblDatabaseReference

HSPB6
type: EnsemblDatabaseReference

RP11-36D19.9
type: EnsemblDatabaseReference

RXFP1
type: EnsemblDatabaseReference

PTPRO DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.25715290586218
p value: 0.00306645440475372
refers to: PTPRO

LGALS3
type: EnsemblDatabaseReference

GJA1
type: EnsemblDatabaseReference

AC006116.20
type: EnsemblDatabaseReference

CLU
type: EnsemblDatabaseReference

RIPK3
type: EnsemblDatabaseReference

RP11-153M7.3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.46525767279664
p value: 1.13644343650091E-11
refers to: RP11-153M7.3

CRYBB1
type: EnsemblDatabaseReference

LTBP3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.36458451000306
p value: 1.42147240639532E-24
refers to: LTBP3

PNLDC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 6.36753118828844E-7
refers to: PNLDC1

COL14A1
type: EnsemblDatabaseReference

GBP1
type: EnsemblDatabaseReference

CXCL11 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.96264159261307
p value: 6.99211839694762E-6
refers to: CXCL11

ABTB2
type: EnsemblDatabaseReference

TBC1D30
type: EnsemblDatabaseReference

PVRL4
type: EnsemblDatabaseReference

KHDRBS3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.62120776820234
p value: 0.02998321468677
refers to: KHDRBS3

AL589743.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.63967781802098
p value: 3.64430564540295E-11
refers to: AL589743.1

CYTIP
type: EnsemblDatabaseReference

MAGEB1
type: EnsemblDatabaseReference

RXFP1
type: EnsemblDatabaseReference

AURKC
type: EnsemblDatabaseReference

ANO9 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.46875673018063
p value: 0.0402159097468779
refers to: ANO9

LINC00200 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 1.96526424704821E-7
refers to: LINC00200

GJA1
type: EnsemblDatabaseReference

ZNF302 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.24005190317555
p value: 2.30520387230979E-4
refers to: ZNF302

EGR3
type: EnsemblDatabaseReference

ACAP1
type: EnsemblDatabaseReference

NFAM1
type: EnsemblDatabaseReference

NMRK1
type: EnsemblDatabaseReference

CMPK2
type: EnsemblDatabaseReference

CRYBB1
type: EnsemblDatabaseReference

HERC5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.34232891608651
p value: 1.50566335706149E-42
refers to: HERC5

NPFFR2
type: EnsemblDatabaseReference

COL14A1
type: EnsemblDatabaseReference

VWCE
type: EnsemblDatabaseReference

ATG9B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.93256335556426
p value: 0.0221416626977533
refers to: ATG9B

RCOR2
type: EnsemblDatabaseReference

PVRL4
type: EnsemblDatabaseReference

SYNGR3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.56500872213576
p value: 1.24222990167397E-6
refers to: SYNGR3

C10orf10 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.24894129586105
p value: 0.00128598114135861
refers to: C10orf10

CYTIP
type: EnsemblDatabaseReference

PDE1C
type: EnsemblDatabaseReference

ZNF302
type: EnsemblDatabaseReference

FLNC
type: EnsemblDatabaseReference

AURKC
type: EnsemblDatabaseReference

BIK
type: EnsemblDatabaseReference

CDKN2A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.00591788445827
p value: 3.75277029331924E-25
refers to: CDKN2A

CPED1
type: EnsemblDatabaseReference

MEST DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.13689591146312
p value: 2.0853595736738E-11
refers to: MEST

PTGS2
type: EnsemblDatabaseReference

NFAM1
type: EnsemblDatabaseReference

RIPK3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.2693480012911
p value: 0.0185674673402476
refers to: RIPK3

OAS1
type: EnsemblDatabaseReference

VAT1L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.4584762736909
p value: 1.29195784371941E-7
refers to: VAT1L

MARCKS
type: EnsemblDatabaseReference

ANK3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.2656683534021
p value: 0.00831001000359368
refers to: ANK3

PARP10
type: EnsemblDatabaseReference

SAMSN1
type: EnsemblDatabaseReference

PDE1C
type: EnsemblDatabaseReference

LYZ
type: EnsemblDatabaseReference

BIK
type: EnsemblDatabaseReference

FLNC
type: EnsemblDatabaseReference

DLX2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.78585200609278
p value: 0.0182418509482426
refers to: DLX2

TAP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.7232045566032
p value: 3.3730253116872E-65
refers to: TAP1

CD300A
type: EnsemblDatabaseReference

RP11-284F21.9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.33702659714167
p value: 5.8769782742407E-5
refers to: RP11-284F21.9

KIAA0040 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.08834941795237
p value: 7.82043373575368E-18
refers to: KIAA0040

NR5A1
type: EnsemblDatabaseReference

ODF3B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.12810019478291
p value: 4.35409861355352E-21
refers to: ODF3B

HORMAD1
type: EnsemblDatabaseReference

LINC01140
type: EnsemblDatabaseReference

ZNF772
type: EnsemblDatabaseReference

ARHGAP20
type: EnsemblDatabaseReference

MARCKS
type: EnsemblDatabaseReference

SAMSN1
type: EnsemblDatabaseReference

CEMIP
type: EnsemblDatabaseReference

IL4I1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.98461809224151
p value: 0.016195151960818
refers to: IL4I1

STAG3
type: EnsemblDatabaseReference

LYZ
type: EnsemblDatabaseReference

CACNA1A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.10011638362092
p value: 0.0275059089111196
refers to: CACNA1A

KMO
type: EnsemblDatabaseReference

AC011899.9
type: EnsemblDatabaseReference

IFIT1
type: EnsemblDatabaseReference

RGS2
type: EnsemblDatabaseReference

ANGPT1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.8456082791605
p value: 0.00183052572451986
refers to: ANGPT1

GLIS3
type: EnsemblDatabaseReference

FAM127C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.76272432829166
p value: 3.94983801739674E-13
refers to: FAM127C

HORMAD1
type: EnsemblDatabaseReference

ROBO1
type: EnsemblDatabaseReference

CALB2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.57636781898125
p value: 2.10462006118649E-34
refers to: CALB2

LINC01140
type: EnsemblDatabaseReference

ZNF772
type: EnsemblDatabaseReference

RSAD2
type: EnsemblDatabaseReference

SLAMF1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.31019477174075
p value: 0.0393105426101736
refers to: SLAMF1

FIBCD1
type: EnsemblDatabaseReference

TSPAN2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.85916049574076
p value: 0.0378999382076452
refers to: TSPAN2

FCRLA
type: EnsemblDatabaseReference

LPAR5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.32534125312367
p value: 3.23201724157188E-4
refers to: LPAR5

MAP10
type: EnsemblDatabaseReference

NGFR
type: EnsemblDatabaseReference

RP11-1112C15.1
type: EnsemblDatabaseReference

CEMIP
type: EnsemblDatabaseReference

GATA2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.34788374652627
p value: 1.1301151740272E-15
refers to: GATA2

STAG3
type: EnsemblDatabaseReference

RHBDL3
type: EnsemblDatabaseReference

COL1A2
type: EnsemblDatabaseReference

RGS2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.22245534265983
p value: 2.06589591979693E-16
refers to: RGS2

NAGS
type: EnsemblDatabaseReference

IGFBP5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.06821706825716
p value: 6.94910842105811E-83
refers to: IGFBP5

KMO
type: EnsemblDatabaseReference

RP11-452C13.1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.43520770928021
p value: 8.91868839428747E-5
refers to: RP11-452C13.1

CORO2A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.28509571882955
p value: 0.0149285045535165
refers to: CORO2A

AC011899.9
type: EnsemblDatabaseReference

EOMES
type: EnsemblDatabaseReference

RGS2
type: EnsemblDatabaseReference

IFIT1
type: EnsemblDatabaseReference

JAK3
type: EnsemblDatabaseReference

SEPP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.04149814087511
p value: 3.08778270107037E-4
refers to: SEPP1

RP4-647J21.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23617008354851
p value: 1.82427309635011E-6
refers to: RP4-647J21.1

TSHZ3
type: EnsemblDatabaseReference

ROBO1
type: EnsemblDatabaseReference

ST14 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.04706233142686
p value: 7.03128727119115E-9
refers to: ST14

SLC12A3
type: EnsemblDatabaseReference

FIBCD1
type: EnsemblDatabaseReference

GNG11 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.61655398343207
p value: 9.85956112649762E-24
refers to: GNG11

BCL11A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.90371239976964
p value: 0.0075076642684695
refers to: BCL11A

FCRLA
type: EnsemblDatabaseReference

NGFR
type: EnsemblDatabaseReference

HLA-F DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.72455599005305
p value: 2.76868637375732E-12
refers to: HLA-F

RP11-1112C15.1
type: EnsemblDatabaseReference

OLFML3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.34216594176436
p value: 8.38054069731257E-8
refers to: OLFML3

RHBDL3
type: EnsemblDatabaseReference

SNCA DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.06946122783684
p value: 4.42515092378024E-4
refers to: SNCA

NAGS
type: EnsemblDatabaseReference

RP11-452C13.1
type: EnsemblDatabaseReference

HIST1H2BJ
type: EnsemblDatabaseReference

DOCK4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.27286409373883
p value: 0.00906930258462632
refers to: DOCK4

TMEM139
type: EnsemblDatabaseReference

RP11-321E2.3
type: EnsemblDatabaseReference

LINC00639 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.42202818021973
p value: 1.83543980395316E-7
refers to: LINC00639

JAK3
type: EnsemblDatabaseReference

ZEB1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.03442559680024
p value: 0.00270840422647586
refers to: ZEB1

SLITRK6
type: EnsemblDatabaseReference

LINC00958
type: EnsemblDatabaseReference

ID2
type: EnsemblDatabaseReference

MOSPD3
type: EnsemblDatabaseReference

SLFN5
type: EnsemblDatabaseReference

(Sample) organism/Homo sapiens
type: Homo sapiens
property type: organism
property value: Homo sapiens

TNFRSF13C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.71826890085545
p value: 4.81015220258496E-4
refers to: TNFRSF13C

PRAME
type: EnsemblDatabaseReference

PLXDC2
type: EnsemblDatabaseReference

HIST1H2BJ
type: EnsemblDatabaseReference

RP11-321E2.3
type: EnsemblDatabaseReference

MSRB3
type: EnsemblDatabaseReference

PKIB
type: EnsemblDatabaseReference

SLITRK6
type: EnsemblDatabaseReference

LINC00958
type: EnsemblDatabaseReference

SORT1
type: EnsemblDatabaseReference

ID2
type: EnsemblDatabaseReference

FKBP1B
type: EnsemblDatabaseReference

CD226
type: EnsemblDatabaseReference

MYEOV DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.67205901971653
p value: 0.0275795052245008
refers to: MYEOV

TPM2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.49939169292842
p value: 8.15263002332311E-45
refers to: TPM2

TMEM169
type: EnsemblDatabaseReference

PRAME
type: EnsemblDatabaseReference

ATP8A1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10990407493659
p value: 0.0230079460972799
refers to: ATP8A1

MSRB3
type: EnsemblDatabaseReference

EPS8L2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 1.35921397931967E-7
refers to: EPS8L2

ATP6V0D2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.11323928652579
p value: 0.006962685954585
refers to: ATP6V0D2

GATA2
type: EnsemblDatabaseReference

FYN
type: EnsemblDatabaseReference

C3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.68095458000652
p value: 1.25046361022808E-24
refers to: C3

ANTXR2
type: EnsemblDatabaseReference

FKBP1B
type: EnsemblDatabaseReference

AIM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.9393539355582
p value: 8.41962252648526E-34
refers to: AIM1

RP11-284F21.9
type: EnsemblDatabaseReference

FAM13A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.18294629888558
p value: 0.0146452568281846
refers to: FAM13A

BOK-AS1
type: EnsemblDatabaseReference

TCN1
type: EnsemblDatabaseReference

CTHRC1
type: EnsemblDatabaseReference

FYN
type: EnsemblDatabaseReference

GPNMB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.08506629482996
p value: 3.33713515818099E-15
refers to: GPNMB

C10orf10
type: EnsemblDatabaseReference

CABLES1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.16769019425129
p value: 0.0477974252141993
refers to: CABLES1

ROPN1L UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.06187429310027
p value: 0.00330062779709978
refers to: ROPN1L

ALOX5
type: EnsemblDatabaseReference

ARG2
type: EnsemblDatabaseReference

CLEC12A
type: EnsemblDatabaseReference

CCDC146
type: EnsemblDatabaseReference

H2BFS DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.90958759478616
p value: 1.36243148518688E-8
refers to: H2BFS

FKBP10 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.91039600648807
p value: 8.37216815402624E-13
refers to: FKBP10

FSD1
type: EnsemblDatabaseReference

BOK-AS1
type: EnsemblDatabaseReference

COX8C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.62224030815454
p value: 0.00111871877374051
refers to: COX8C

RP11-47A8.5
type: EnsemblDatabaseReference

ERG
type: EnsemblDatabaseReference

PTPRO
type: EnsemblDatabaseReference

HIST1H1C
type: EnsemblDatabaseReference

PHLDB3
type: EnsemblDatabaseReference

ARG2
type: EnsemblDatabaseReference

EVPL
type: EnsemblDatabaseReference

HMOX1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.76793461139463
p value: 1.95211398865392E-9
refers to: HMOX1

CLEC12A
type: EnsemblDatabaseReference

EIF4E3
type: EnsemblDatabaseReference

ISG20
type: EnsemblDatabaseReference

EPS8L2
type: EnsemblDatabaseReference

RYR1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.62536011121079
p value: 0.00734444001576958
refers to: RYR1

CPXM1
type: EnsemblDatabaseReference

FSD1
type: EnsemblDatabaseReference

MPEG1
type: EnsemblDatabaseReference

DSC2
type: EnsemblDatabaseReference

ERG
type: EnsemblDatabaseReference

HIST1H1C
type: EnsemblDatabaseReference

PHLDB3
type: EnsemblDatabaseReference

NDUFA4L2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.98879402127308
p value: 1.40891355331402E-14
refers to: NDUFA4L2

IL16 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.16896079542861
p value: 2.0483033884574E-10
refers to: IL16

PPM1M
type: EnsemblDatabaseReference

ISG20
type: EnsemblDatabaseReference

EPS8L2
type: EnsemblDatabaseReference

SLC5A9 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.14636623980512
p value: 0.00372726421100579
refers to: SLC5A9

CLDN7
type: EnsemblDatabaseReference

GNG4 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.1195905224501
p value: 6.15376463323527E-25
refers to: GNG4

AC011625.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.52036015473967
p value: 0.00739662254449782
refers to: AC011625.1

HIST2H2BE
type: EnsemblDatabaseReference

MPEG1
type: EnsemblDatabaseReference

RP11-330A16.1
type: EnsemblDatabaseReference

NRN1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.55961851792177
p value: 2.85000746484831E-10
refers to: NRN1

PKIB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.52516371103728
p value: 4.87576709803622E-4
refers to: PKIB

STRA6
type: EnsemblDatabaseReference

FAM115C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.14015800155441
p value: 0.00228539584715464
refers to: FAM115C

INHBA
type: EnsemblDatabaseReference

PTGFR
type: EnsemblDatabaseReference

CLDN7
type: EnsemblDatabaseReference

CLDN7 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.21844168520106
p value: 0.01490336754914
refers to: CLDN7

DDX60
type: EnsemblDatabaseReference

PGF
type: EnsemblDatabaseReference

HIST2H2BE
type: EnsemblDatabaseReference

ZNF595
type: EnsemblDatabaseReference

CKB
type: EnsemblDatabaseReference

SMAD1
type: EnsemblDatabaseReference

GPR126
type: EnsemblDatabaseReference

CYB5R2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.31860708748095
p value: 6.53464988778331E-5
refers to: CYB5R2

IGFBP3
type: EnsemblDatabaseReference

TRIB2
type: EnsemblDatabaseReference

CLEC5A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.94822177951631
p value: 1.46778232225041E-13
refers to: CLEC5A

GSN
type: EnsemblDatabaseReference

CKM
type: EnsemblDatabaseReference

E-GEOD-55123
type: rnaseq mrna differential
RO_0002162: Homo sapiens
description: AML3 cells were treated with Azacytidine and compared against untreated cells We used RNA-Seq to detail the global programme of gene expression in human untreated and Azacytidine treated AML3 cells

PPM1E UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.17169715950366
p value: 3.59988807385185E-6
refers to: PPM1E

SSTR2
type: EnsemblDatabaseReference

TNFRSF13C
type: EnsemblDatabaseReference

MIR600HG UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.77651147868113
p value: 0.0117687547614278
refers to: MIR600HG

PGF
type: EnsemblDatabaseReference

FAM111B
type: EnsemblDatabaseReference

STAP1
type: EnsemblDatabaseReference

AF146191.4
type: EnsemblDatabaseReference

SMAD1
type: EnsemblDatabaseReference

GPR126
type: EnsemblDatabaseReference

CES3
type: EnsemblDatabaseReference

FAM198B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.53648897857038
p value: 2.49687780567752E-22
refers to: FAM198B

IGFBP3
type: EnsemblDatabaseReference

HLA-C
type: EnsemblDatabaseReference

PLK2
type: EnsemblDatabaseReference

BIK DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.18868805963571
p value: 1.50580100905028E-4
refers to: BIK

GSN
type: EnsemblDatabaseReference

PDLIM1
type: EnsemblDatabaseReference

IL10RA DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.07042256033127
p value: 3.22597539081078E-6
refers to: IL10RA

CKM
type: EnsemblDatabaseReference

RP1-152L7.5
type: EnsemblDatabaseReference

RGS1
type: EnsemblDatabaseReference

TNFRSF13C
type: EnsemblDatabaseReference

ALOX5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.01239804187117
p value: 2.51167281502967E-22
refers to: ALOX5

ST8SIA6-AS1
type: EnsemblDatabaseReference

PRR16
type: EnsemblDatabaseReference

UCN2 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.94907211252949
p value: 0.0166592131717467
refers to: UCN2

FAM111B
type: EnsemblDatabaseReference

STAP1
type: EnsemblDatabaseReference

CD14
type: EnsemblDatabaseReference

FKBP10
type: EnsemblDatabaseReference

PFN2
type: EnsemblDatabaseReference

S100P
type: EnsemblDatabaseReference

CES3
type: EnsemblDatabaseReference

CD86
type: EnsemblDatabaseReference

HERC5
type: EnsemblDatabaseReference

MAFB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.9692353641132
p value: 4.36403778751075E-14
refers to: MAFB

HLA-C
type: EnsemblDatabaseReference

PLK2
type: EnsemblDatabaseReference

RGS1
type: EnsemblDatabaseReference

CDKN2A
type: EnsemblDatabaseReference

PRAM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.41066281033583
p value: 1.27304427394084E-18
refers to: PRAM1

MEST
type: EnsemblDatabaseReference

ST8SIA6-AS1
type: EnsemblDatabaseReference

PRR16
type: EnsemblDatabaseReference

CD14
type: EnsemblDatabaseReference

FKBP10
type: EnsemblDatabaseReference

ENO2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.27056486846198
p value: 1.70110220255254E-17
refers to: ENO2

FJX1
type: EnsemblDatabaseReference

CD86
type: EnsemblDatabaseReference

FGFR1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23560369993799
p value: 3.80139256319426E-10
refers to: FGFR1

CAMK2B
type: EnsemblDatabaseReference

PRTFDC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.52496813068897
p value: 0.00771592900734662
refers to: PRTFDC1

CYB5R2
type: EnsemblDatabaseReference

CDKN2A
type: EnsemblDatabaseReference

KIF13A
type: EnsemblDatabaseReference

EDIL3
type: EnsemblDatabaseReference

KCP
type: EnsemblDatabaseReference

ANXA1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.27671730868646
p value: 1.19229752001321E-29
refers to: ANXA1

NOD2
type: EnsemblDatabaseReference

UBE2L6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.43567347693435
p value: 2.23364407605962E-56
refers to: UBE2L6

RBP4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23530389060502
p value: 0.00106879825244977
refers to: RBP4

ZNF501 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 1.75245242698059E-7
refers to: ZNF501

TGFBI
type: EnsemblDatabaseReference

PARP14 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.29223904007684
p value: 2.94590205733835E-12
refers to: PARP14

FERMT2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.3679545632598
p value: 1.20766709356546E-4
refers to: FERMT2

DOC2B
type: EnsemblDatabaseReference

PGF DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.72395309723442
p value: 0.0208345798618259
refers to: PGF

PDE1C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.17912770787045
p value: 5.80826555109211E-5
refers to: PDE1C

MEIS2
type: EnsemblDatabaseReference

TLE2
type: EnsemblDatabaseReference

DCAF4L1
type: EnsemblDatabaseReference

SERPINB2
type: EnsemblDatabaseReference

HLA-B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.42059079940353
p value: 2.45627858846618E-97
refers to: HLA-B

ADAM28
type: EnsemblDatabaseReference

MYO1B
type: EnsemblDatabaseReference

ITGB7 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.56391249698885
p value: 1.29457727273818E-33
refers to: ITGB7

S100A9
type: EnsemblDatabaseReference

GIMAP1
type: EnsemblDatabaseReference

TNIK
type: EnsemblDatabaseReference

EVA1B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.44168996340846
p value: 4.05012287496281E-5
refers to: EVA1B

CALB2
type: EnsemblDatabaseReference

ECHDC2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.00368435097952
p value: 4.74637022702028E-7
refers to: ECHDC2

HR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.42505075735323
p value: 0.00578159220229787
refers to: HR

TLE2
type: EnsemblDatabaseReference

DCAF4L1
type: EnsemblDatabaseReference

ANTXR2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.03655685298818
p value: 4.6526552552767E-17
refers to: ANTXR2

RP5-884M6.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.85544109669323
p value: 0.0149620078493768
refers to: RP5-884M6.1

SERPINB2
type: EnsemblDatabaseReference

TENC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.42544541951634
p value: 2.37694897900938E-10
refers to: TENC1

SFRP2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.95214473450881
p value: 2.58273498247746E-21
refers to: SFRP2

H19 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 2.12023968853008E-66
refers to: H19

PTPN13 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.44339222927463
p value: 0.00846956870630219
refers to: PTPN13

LY96
type: EnsemblDatabaseReference

MYO1B
type: EnsemblDatabaseReference

PI15
type: EnsemblDatabaseReference

TNIK
type: EnsemblDatabaseReference

CALB2
type: EnsemblDatabaseReference

STAB1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.87152384092667
p value: 7.33964307627844E-34
refers to: STAB1

NFE2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.92799779799157
p value: 1.09500646705743E-12
refers to: NFE2

CCL2
type: EnsemblDatabaseReference

IFI27
type: EnsemblDatabaseReference

CHI3L1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.14759961165015
p value: 4.50223794233119E-29
refers to: CHI3L1

KIAA0226L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.22953727819124
p value: 1.05714463554267E-9
refers to: KIAA0226L

TRANK1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.43827293897027
p value: 2.42534816560472E-18
refers to: TRANK1

PCED1B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.87857586031508
p value: 0.0398349250850722
refers to: PCED1B

DPY19L2P1
type: EnsemblDatabaseReference

SYCE2 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.03875423610539
p value: 0.00653681988342668
refers to: SYCE2

MMP12 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.90007346840205
p value: 2.87657698326972E-17
refers to: MMP12

LY96
type: EnsemblDatabaseReference

C15orf52 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.08277992435267
p value: 5.79937032607387E-14
refers to: C15orf52

TMEM25 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.87485369922921
p value: 0.00839607633317756
refers to: TMEM25

GMPR
type: EnsemblDatabaseReference

MMP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.83264214159452
p value: 6.1867011875846E-38
refers to: MMP1

H1F0
type: EnsemblDatabaseReference

FAM127C
type: EnsemblDatabaseReference

ALPK3
type: EnsemblDatabaseReference

CDH10 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 1.52626159332638E-8
refers to: CDH10

GBP2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.92762431108579
p value: 2.8772332443451E-19
refers to: GBP2

PDZRN3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.57913396809596
p value: 4.77438097193905E-9
refers to: PDZRN3

DPY19L2P1
type: EnsemblDatabaseReference

ITGA3
type: EnsemblDatabaseReference

MAPK6PS4 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 3.01205604531005
p value: 0.00443287649985244
refers to: MAPK6PS4

PLEKHG4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.13877225961338
p value: 2.66612016911301E-26
refers to: PLEKHG4

TNIK DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.29631763829969
p value: 1.07541593620534E-9
refers to: TNIK

DHX58
type: EnsemblDatabaseReference

CSF1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.50719501395521
p value: 9.26237197914922E-5
refers to: CSF1

HCRTR2
type: EnsemblDatabaseReference

TGFBI DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.09594508367721
p value: 4.36226185684232E-124
refers to: TGFBI

IFI44 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.98015206257742
p value: 1.37127394214285E-73
refers to: IFI44

RP4-781K5.6
type: EnsemblDatabaseReference

UNC5B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.15117051606601
p value: 1.11759607712379E-16
refers to: UNC5B

NCALD
type: EnsemblDatabaseReference

PIWIL2
type: EnsemblDatabaseReference

ADAMTS5
type: EnsemblDatabaseReference

SIGLEC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.89162283658048
p value: 4.9674414487234E-20
refers to: SIGLEC1

H1F0
type: EnsemblDatabaseReference

DDX58
type: EnsemblDatabaseReference

ITGA3
type: EnsemblDatabaseReference

IFIT3
type: EnsemblDatabaseReference

NLRC4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.13457171338166
p value: 0.0117687547614278
refers to: NLRC4

STAMBPL1
type: EnsemblDatabaseReference

SMG1P4
type: EnsemblDatabaseReference

SLC39A4
type: EnsemblDatabaseReference

CLEC2B
type: EnsemblDatabaseReference

NCAM2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.0334519174882
p value: 2.70254133986899E-9
refers to: NCAM2

RP4-781K5.6
type: EnsemblDatabaseReference

HSD11B1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.09007852902984
p value: 5.6791287036278E-28
refers to: HSD11B1

TBX1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0312665775338903
refers to: TBX1

NCALD
type: EnsemblDatabaseReference

PIWIL2
type: EnsemblDatabaseReference

ADAMTS5
type: EnsemblDatabaseReference

RP11-497G19.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.7490224926076
p value: 1.3830502094811E-5
refers to: RP11-497G19.1

LPAR6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.88039866751729
p value: 0.0422939856582672
refers to: LPAR6

OASL
type: EnsemblDatabaseReference

MMP1
type: EnsemblDatabaseReference

RP5-1157M23.2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.53077818253504
p value: 0.0192427354633882
refers to: RP5-1157M23.2

NID1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.39153792236599
p value: 4.58943763677826E-26
refers to: NID1

IFIT3
type: EnsemblDatabaseReference

CTD-2357A8.3 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.73185811812264
p value: 1.79089530023703E-4
refers to: CTD-2357A8.3

SMG1P4
type: EnsemblDatabaseReference

SLC39A4
type: EnsemblDatabaseReference

TGFA
type: EnsemblDatabaseReference

SERPINF1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.07430669466876
p value: 0.00666214187440245
refers to: SERPINF1

CLEC2B
type: EnsemblDatabaseReference

SLC27A3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.26261021280586
p value: 6.6291100635109E-6
refers to: SLC27A3

IL32
type: EnsemblDatabaseReference

NFE2
type: EnsemblDatabaseReference

HIST1H2AC
type: EnsemblDatabaseReference

RCOR2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.21733469234407
p value: 3.29650394196254E-9
refers to: RCOR2

LINC01296 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.43920343008728
p value: 0.0247214104106675
refers to: LINC01296

NMRK1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.54726810433719
p value: 1.68064492880827E-4
refers to: NMRK1

MMP1
type: EnsemblDatabaseReference

PARD6A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.0806519877047
p value: 2.43093748794988E-6
refers to: PARD6A

SLC9A5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.03870311707708
p value: 8.0891115785252E-4
refers to: SLC9A5

DSC2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.1543584276025
p value: 5.39159053828301E-8
refers to: DSC2

IL32
type: EnsemblDatabaseReference

LINC00639
type: EnsemblDatabaseReference

AIM2
type: EnsemblDatabaseReference

RP11-61L23.2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.46870217808673
p value: 0.00125076494925921
refers to: RP11-61L23.2

EEF1A2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.2715521822545
p value: 2.06107062234129E-22
refers to: EEF1A2

SLFN5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.81777082415313
p value: 1.13208206623834E-38
refers to: SLFN5

EPHA3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.12772560246717
p value: 3.32633977935255E-9
refers to: EPHA3

KIAA0226L
type: EnsemblDatabaseReference

ANG
type: EnsemblDatabaseReference

EGR3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.92034739732519
p value: 0.0163854224609707
refers to: EGR3

SEPP1
type: EnsemblDatabaseReference

EMR1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.37468123774769
p value: 8.61389864885417E-4
refers to: EMR1

ZNF467 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.44952825400434
p value: 3.76704521384898E-21
refers to: ZNF467

LPL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.3598882040417
p value: 1.56577330030534E-9
refers to: LPL

PRDM1
type: EnsemblDatabaseReference

CCDC146 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.35822004351699
p value: 0.0136267091100439
refers to: CCDC146

SAMD9L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.60831801759398
p value: 8.90508631289315E-17
refers to: SAMD9L

MMP13
type: EnsemblDatabaseReference

IL2RG DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.5890067011239
p value: 0.00154059806591076
refers to: IL2RG

ABTB2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.75494804134926
p value: 0.00320688175195706
refers to: ABTB2

SERPINB10 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.48398662161291
p value: 9.79601488072092E-7
refers to: SERPINB10

RAB27B
type: EnsemblDatabaseReference

PPM1M DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.91711566141251
p value: 3.52438016957467E-55
refers to: PPM1M

IL32 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.7084616528136
p value: 6.62300939914248E-19
refers to: IL32

TNN
type: EnsemblDatabaseReference

PRR5L
type: EnsemblDatabaseReference

RP11-103J17.2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.00281321775950298
refers to: RP11-103J17.2

SYNGR3
type: EnsemblDatabaseReference

KIAA0226L
type: EnsemblDatabaseReference

CHRM4
type: EnsemblDatabaseReference

S100P DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.11690842814709
p value: 2.17323598143225E-10
refers to: S100P

SEPP1
type: EnsemblDatabaseReference

OAS2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.54318774799405
p value: 2.44220355736323E-23
refers to: OAS2

ZFP36L1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.38532486830178
p value: 5.95739714951145E-35
refers to: ZFP36L1

LINC01096 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.23413446049948
p value: 0.0308476566369389
refers to: LINC01096

FGD2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.59992929805017
p value: 1.21403167783217E-8
refers to: FGD2

AC106875.1
type: EnsemblDatabaseReference

PRL
type: EnsemblDatabaseReference

SDC1
type: EnsemblDatabaseReference

GPR158
type: EnsemblDatabaseReference

NFE4
type: EnsemblDatabaseReference

DNASE2
type: EnsemblDatabaseReference

RP11-1220K2.2
type: EnsemblDatabaseReference

SYNGR3
type: EnsemblDatabaseReference

HLA-F
type: EnsemblDatabaseReference

SAMD9L
type: EnsemblDatabaseReference

CD14 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.0304928136478
p value: 2.23394740410628E-5
refers to: CD14

CTC-510F12.4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.01435368818128
p value: 0.0325577128196555
refers to: CTC-510F12.4

KIAA1244 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.02456164549807
p value: 1.00563213608612E-13
refers to: KIAA1244

PRL
type: EnsemblDatabaseReference

SH2D3C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.95474560410034
p value: 1.79078695071507E-11
refers to: SH2D3C

SDC1
type: EnsemblDatabaseReference

WFS1
type: EnsemblDatabaseReference

NFE4
type: EnsemblDatabaseReference

FAM198B
type: EnsemblDatabaseReference

RIN2
type: EnsemblDatabaseReference

DNASE2
type: EnsemblDatabaseReference

HLA-DMB
type: EnsemblDatabaseReference

C3
type: EnsemblDatabaseReference

POU3F2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.53769617012503
p value: 0.00101631363492079
refers to: POU3F2

SARM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.1117669580334
p value: 0.00952258718769284
refers to: SARM1

HLA-F
type: EnsemblDatabaseReference

STC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.0035781048527
p value: 0.0289887942002581
refers to: STC1

SAMD9L
type: EnsemblDatabaseReference

HLA-H DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.43473481191713
p value: 1.29494382759755E-16
refers to: HLA-H

PIWIL2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.48700414143296
p value: 5.28446050973483E-5
refers to: PIWIL2

ELFN1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.05880334868783
p value: 0.0205493198801121
refers to: ELFN1

BCL11A
type: EnsemblDatabaseReference

MAGEB1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 7.39420875675537E-5
refers to: MAGEB1

KMO DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.20835657380071
p value: 6.23166505078645E-5
refers to: KMO

RIN2
type: EnsemblDatabaseReference

KCNC3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.25038104015042
p value: 3.24723115941158E-5
refers to: KCNC3

CHRM5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.42172776941356
p value: 8.01014022045564E-6
refers to: CHRM5

LINC00200
type: EnsemblDatabaseReference

GEM
type: EnsemblDatabaseReference

KHDRBS2
type: EnsemblDatabaseReference

CRIPAK
type: EnsemblDatabaseReference

ISLR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.21187290259967
p value: 2.72945132466242E-4
refers to: ISLR

C3
type: EnsemblDatabaseReference

RGCC
type: EnsemblDatabaseReference

MIR4674HG
type: EnsemblDatabaseReference

LBH
type: EnsemblDatabaseReference

BCL11A
type: EnsemblDatabaseReference

CXCL11
type: EnsemblDatabaseReference

CD93
type: EnsemblDatabaseReference

SNPH DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.10698732050032
p value: 0.00162256799360203
refers to: SNPH

HIST1H2AC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.17777255068193
p value: 4.47395627404591E-18
refers to: HIST1H2AC

PDGFD
type: EnsemblDatabaseReference

TNR
type: EnsemblDatabaseReference

LINC01296
type: EnsemblDatabaseReference

JUN DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.69797772468928
p value: 5.27226534597457E-20
refers to: JUN

RASD2
type: EnsemblDatabaseReference

CLEC5A
type: EnsemblDatabaseReference

AC093642.3
type: EnsemblDatabaseReference

CPLX1
type: EnsemblDatabaseReference

RP5-884M6.1
type: EnsemblDatabaseReference

GAS1
type: EnsemblDatabaseReference

KHDRBS2
type: EnsemblDatabaseReference

TNFSF13B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.59679126962198
p value: 5.85111189269068E-20
refers to: TNFSF13B

ETV7
type: EnsemblDatabaseReference

RGCC
type: EnsemblDatabaseReference

MIR4674HG
type: EnsemblDatabaseReference

ABHD4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.53220587036573
p value: 2.20254075217952E-6
refers to: ABHD4

CXCL11
type: EnsemblDatabaseReference

IFIT1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.68193083972521
p value: 3.25981521855226E-26
refers to: IFIT1

TBX3
type: EnsemblDatabaseReference

CD93
type: EnsemblDatabaseReference

H1F0 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.38634465976628
p value: 1.6542232079504E-82
refers to: H1F0

CTB-133G6.1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.9175142806853
p value: 3.4796329714173E-6
refers to: CTB-133G6.1

TNR
type: EnsemblDatabaseReference

PDGFD
type: EnsemblDatabaseReference

MAFB
type: EnsemblDatabaseReference

RASD2
type: EnsemblDatabaseReference

AC093642.3
type: EnsemblDatabaseReference

IGFLR1
type: EnsemblDatabaseReference

RASD2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.07522428076128
p value: 1.87691841502377E-13
refers to: RASD2

MAGEC1
type: EnsemblDatabaseReference

CPLX1
type: EnsemblDatabaseReference

CXXC5
type: EnsemblDatabaseReference

ETV7
type: EnsemblDatabaseReference

OLFML3
type: EnsemblDatabaseReference

PARP9
type: EnsemblDatabaseReference

HSPA6
type: EnsemblDatabaseReference

FUCA1
type: EnsemblDatabaseReference

MESP1
type: EnsemblDatabaseReference

SERPINB10
type: EnsemblDatabaseReference

AFAP1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.01488274690056
p value: 0.0048971871616866
refers to: AFAP1

SNPH
type: EnsemblDatabaseReference

IFITM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.29974947759844
p value: 6.71854465363207E-28
refers to: IFITM1

MAFB
type: EnsemblDatabaseReference

NRG1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.00933277355073509
refers to: NRG1

FUCA1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.53691882880424
p value: 7.21137770931717E-13
refers to: FUCA1

MAGEC1
type: EnsemblDatabaseReference

IGFLR1
type: EnsemblDatabaseReference

LGALS3BP
type: EnsemblDatabaseReference

FCGR2B
type: EnsemblDatabaseReference

TENC1
type: EnsemblDatabaseReference

MEIOB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.20897313180496
p value: 0.00109605626705503
refers to: MEIOB

CXXC5
type: EnsemblDatabaseReference

OLFML3
type: EnsemblDatabaseReference

DUXAP8
type: EnsemblDatabaseReference

NFE4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.47932776070791
p value: 0.014728521064789
refers to: NFE4

PTGDS
type: EnsemblDatabaseReference

HSPA6
type: EnsemblDatabaseReference

PHLDA1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.52444999907964
p value: 2.69029593141107E-13
refers to: PHLDA1

PRTG
type: EnsemblDatabaseReference

AC093642.3 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.54900935888048
p value: 0.00178827905413376
refers to: AC093642.3

NAPSB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.68964973249336
p value: 1.19960371446388E-64
refers to: NAPSB

SNPH
type: EnsemblDatabaseReference

PLXNA2
type: EnsemblDatabaseReference

RP5-1157M23.2
type: EnsemblDatabaseReference

FSTL1
type: EnsemblDatabaseReference

RCBTB2
type: EnsemblDatabaseReference

ALPK3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.07235138243063
p value: 1.83603670544957E-18
refers to: ALPK3

TENC1
type: EnsemblDatabaseReference

PCED1B
type: EnsemblDatabaseReference

DUXAP8
type: EnsemblDatabaseReference

RP11-328N19.1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.60398386717472
p value: 0.0176844665128801
refers to: RP11-328N19.1

MMP13 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.00175470845112173
refers to: MMP13

CES3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.75602480056449
p value: 1.66424784532886E-6
refers to: CES3

BANK1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10857912344107
p value: 1.27453489407261E-14
refers to: BANK1

ENHO
type: EnsemblDatabaseReference

KCNK13
type: EnsemblDatabaseReference

TRAF1
type: EnsemblDatabaseReference

GPR158 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.030340060108763
refers to: GPR158

PCDH18 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.69213420509841
p value: 2.33293587005848E-9
refers to: PCDH18

RAB30
type: EnsemblDatabaseReference

LSP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.18249782760726
p value: 1.45501681798494E-28
refers to: LSP1

PLXNA2
type: EnsemblDatabaseReference

GPR68
type: EnsemblDatabaseReference

C6orf223
type: EnsemblDatabaseReference

CFH
type: EnsemblDatabaseReference

SLC12A3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.40266111630587
p value: 0.0
refers to: SLC12A3

S100A8 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.64369467930796
p value: 1.87323570079806E-22
refers to: S100A8

MAPK6PS4
type: EnsemblDatabaseReference

ENHO
type: EnsemblDatabaseReference

ATP6V0D2
type: EnsemblDatabaseReference

FAUP1
type: EnsemblDatabaseReference

KCNK13
type: EnsemblDatabaseReference

PLSCR1
type: EnsemblDatabaseReference

GPR68
type: EnsemblDatabaseReference

C6orf223
type: EnsemblDatabaseReference

AHRR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.017897978359
p value: 1.81208462760432E-44
refers to: AHRR

IL2RG
type: EnsemblDatabaseReference

STAT5A
type: EnsemblDatabaseReference

CABLES1
type: EnsemblDatabaseReference

SERPINI1
type: EnsemblDatabaseReference

CHRM5
type: EnsemblDatabaseReference

ECHDC2
type: EnsemblDatabaseReference

ATP6V0D2
type: EnsemblDatabaseReference

PTAFR
type: EnsemblDatabaseReference

SVEP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.28779362837617
p value: 0.0312084373472122
refers to: SVEP1

FAUP1
type: EnsemblDatabaseReference

LRRC25 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.0567151302392
p value: 3.03756536934141E-9
refers to: LRRC25

PLSCR1
type: EnsemblDatabaseReference

VWA1
type: EnsemblDatabaseReference

MYOM1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.84207319571263
p value: 0.00721279018969954
refers to: MYOM1

LPO
type: EnsemblDatabaseReference

FIBCD1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.38109902698547
p value: 0.00399337504351372
refers to: FIBCD1

MARCKS DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.18020498898642
p value: 7.38631394710118E-18
refers to: MARCKS

EMILIN1
type: EnsemblDatabaseReference

C9orf116
type: EnsemblDatabaseReference

IL2RG
type: EnsemblDatabaseReference

CTB-133G6.1
type: EnsemblDatabaseReference

STAT5A
type: EnsemblDatabaseReference

VWA1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.22734774578923
p value: 6.96855063124434E-5
refers to: VWA1

SPINT1
type: EnsemblDatabaseReference

CHRM5
type: EnsemblDatabaseReference

RHBDL3 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.43814254390343
p value: 0.00159074039081609
refers to: RHBDL3

FSD1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.69950435113835
p value: 0.016307740969712
refers to: FSD1

PTAFR
type: EnsemblDatabaseReference

CORO2A
type: EnsemblDatabaseReference

PTCH1
type: EnsemblDatabaseReference

TBX1
type: EnsemblDatabaseReference

GBP5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.60735110746746
p value: 1.67870804879543E-5
refers to: GBP5

TCN1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.33566844733721
p value: 6.91656210891609E-12
refers to: TCN1

C9orf116
type: EnsemblDatabaseReference

MYOM1
type: EnsemblDatabaseReference

PARP12
type: EnsemblDatabaseReference

CTB-133G6.1
type: EnsemblDatabaseReference

PTPN13
type: EnsemblDatabaseReference

PRTFDC1
type: EnsemblDatabaseReference

UNC5B
type: EnsemblDatabaseReference

SNX20 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.04676038776038
p value: 1.76189601800032E-20
refers to: SNX20

SIGLEC1
type: EnsemblDatabaseReference

PTCH1
type: EnsemblDatabaseReference

SLC9A9
type: EnsemblDatabaseReference

TBX1
type: EnsemblDatabaseReference

MYOM1
type: EnsemblDatabaseReference

SERPINF1
type: EnsemblDatabaseReference

STYK1
type: EnsemblDatabaseReference

ZNF772 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.47015134639379
p value: 0.00692464101882514
refers to: ZNF772

APBA1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.95183902278934
p value: 0.00329764182523408
refers to: APBA1

ATP6V0E2-AS1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.06925073298718
p value: 0.00124244026467708
refers to: ATP6V0E2-AS1

SLC44A4
type: EnsemblDatabaseReference

PRTFDC1
type: EnsemblDatabaseReference

CD69
type: EnsemblDatabaseReference

BMF
type: EnsemblDatabaseReference

PLCB1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.36493996286099
p value: 0.00366012815806634
refers to: PLCB1

ATG9B
type: EnsemblDatabaseReference

AC006116.20 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.72303704862945
p value: 0.0215956185360622
refers to: AC006116.20

STYK1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.13311154046737
p value: 0.0163983757031287
refers to: STYK1

GLIS3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.26546078076837
p value: 2.95487043107231E-5
refers to: GLIS3

ZNF205
type: EnsemblDatabaseReference

OASL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.5346900888551
p value: 4.31138691369266E-11
refers to: OASL

SARM1
type: EnsemblDatabaseReference

SLC9A9
type: EnsemblDatabaseReference

TSHZ3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.22513101463879
p value: 0.0142682559078494
refers to: TSHZ3

SERPINF1
type: EnsemblDatabaseReference

STYK1
type: EnsemblDatabaseReference

B3GNT8 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.99184638575262
p value: 3.04372148918217E-8
refers to: B3GNT8

COL1A2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.70179112721369
p value: 0.0
refers to: COL1A2

SLC44A4
type: EnsemblDatabaseReference

EPAS1
type: EnsemblDatabaseReference

CD69
type: EnsemblDatabaseReference

BMF
type: EnsemblDatabaseReference

FERMT2
type: EnsemblDatabaseReference

MAP7D2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.75169542799397
p value: 8.52189345642478E-4
refers to: MAP7D2

ANGPT1
type: EnsemblDatabaseReference

ATG9B
type: EnsemblDatabaseReference

NPFFR2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.41299843875348
p value: 0.00715653392344591
refers to: NPFFR2

STEAP1
type: EnsemblDatabaseReference

SARM1
type: EnsemblDatabaseReference

SMAD1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.96123908325939
p value: 1.13337767633479E-7
refers to: SMAD1

AC011899.9 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.25997468152466
p value: 1.8380733733286E-35
refers to: AC011899.9

CTC-510F12.4
type: EnsemblDatabaseReference

ITGB7
type: EnsemblDatabaseReference

H2BFS
type: EnsemblDatabaseReference

C19orf38
type: EnsemblDatabaseReference

EPAS1
type: EnsemblDatabaseReference

IL18BP
type: EnsemblDatabaseReference

PTCHD3P2
type: EnsemblDatabaseReference

LRRC18
type: EnsemblDatabaseReference

ANGPT1
type: EnsemblDatabaseReference

PRICKLE2
type: EnsemblDatabaseReference

STAT1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.14936565296697
p value: 4.27774713888992E-36
refers to: STAT1

RP3-325F22.5
type: EnsemblDatabaseReference

PTGER2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.29429874176195
p value: 1.22601835519715E-5
refers to: PTGER2

CTC-510F12.4
type: EnsemblDatabaseReference

TLE2 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.22204217188041
p value: 0.0303174447498397
refers to: TLE2

ITGB7
type: EnsemblDatabaseReference

H2BFS
type: EnsemblDatabaseReference

WNT5B
type: EnsemblDatabaseReference

CALD1
type: EnsemblDatabaseReference

ARID5B
type: EnsemblDatabaseReference

STAT4
type: EnsemblDatabaseReference

FAM13A
type: EnsemblDatabaseReference

JUN
type: EnsemblDatabaseReference

SVEP1
type: EnsemblDatabaseReference

PTCHD3P2
type: EnsemblDatabaseReference

FCGR2C
type: EnsemblDatabaseReference

BOK-AS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.00621120573151153
refers to: BOK-AS1

CFH DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.26599225087819
p value: 8.32707878378599E-15
refers to: CFH

CDKN2B
type: EnsemblDatabaseReference

SERPINI1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.99394361097202
p value: 6.46136620813826E-5
refers to: SERPINI1

HIST2H2BF DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.41826602008163
p value: 0.0180691355711845
refers to: HIST2H2BF

GNG4
type: EnsemblDatabaseReference

SORT1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.26095624182528
p value: 7.37102695645705E-4
refers to: SORT1

LRRC25
type: EnsemblDatabaseReference

GJA1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.59331829100164
p value: 4.75463176142179E-52
refers to: GJA1

WNT5B
type: EnsemblDatabaseReference

EDIL3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.77104739181167
p value: 1.93279497053644E-9
refers to: EDIL3

JUN
type: EnsemblDatabaseReference

HSH2D DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.67657867456963
p value: 5.16800033100524E-97
refers to: HSH2D

FGR
type: EnsemblDatabaseReference

SGK1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.09376602766402
p value: 0.0236647143359089
refers to: SGK1

U82695.5
type: EnsemblDatabaseReference

OTOF
type: EnsemblDatabaseReference

TAC4
type: EnsemblDatabaseReference

CDKN2B
type: EnsemblDatabaseReference

FAM46A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.33170679684948
p value: 3.50149354341626E-26
refers to: FAM46A

LPAR1
type: EnsemblDatabaseReference

SP110
type: EnsemblDatabaseReference

TRANK1
type: EnsemblDatabaseReference

RP11-103J17.2
type: EnsemblDatabaseReference

GNG4
type: EnsemblDatabaseReference

CD84
type: EnsemblDatabaseReference

DDX58 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.11984467368484
p value: 1.33015778300699E-15
refers to: DDX58

ANK3
type: EnsemblDatabaseReference

WFS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.3699621609549
p value: 0.007394929503959
refers to: WFS1

MAGEA1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 6.62024472891983E-6
refers to: MAGEA1

LRRC25
type: EnsemblDatabaseReference

ACRC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.07647965525687
p value: 4.67435606361657E-77
refers to: ACRC

AQP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.07884776179271
p value: 0.00166871456138856
refers to: AQP1

STK31 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.82718957527561
p value: 0.00482165082107018
refers to: STK31

MAGEA1
type: EnsemblDatabaseReference

HELZ2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.41394786482477
p value: 3.17474787785891E-21
refers to: HELZ2

DNM3OS DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0422192945996209
refers to: DNM3OS

PDGFD DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.00872939795183
p value: 2.68572359893693E-5
refers to: PDGFD

TRPM4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.25065306000578
p value: 2.26850432971522E-8
refers to: TRPM4

OTOF
type: EnsemblDatabaseReference

TAC4
type: EnsemblDatabaseReference

TDRD15 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.00555557022847378
refers to: TDRD15

RFTN1
type: EnsemblDatabaseReference

GLI3
type: EnsemblDatabaseReference

LPAR1
type: EnsemblDatabaseReference

CD84
type: EnsemblDatabaseReference

TRANK1
type: EnsemblDatabaseReference

RP11-103J17.2
type: EnsemblDatabaseReference

SSH3
type: EnsemblDatabaseReference

CDX2
type: EnsemblDatabaseReference

RP11-328N19.1
type: EnsemblDatabaseReference

SNX20
type: EnsemblDatabaseReference

MAGEA1
type: EnsemblDatabaseReference

BMF DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.26687071099145
p value: 4.83572473227686E-28
refers to: BMF

HDHD3
type: EnsemblDatabaseReference

SH2D3C
type: EnsemblDatabaseReference

HIST1H2BJ DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.90437359429164
p value: 0.0242062104570883
refers to: HIST1H2BJ

RP11-497G19.2
type: EnsemblDatabaseReference

TPM2
type: EnsemblDatabaseReference

NOD2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.70113400953985
p value: 1.01987386792074E-17
refers to: NOD2

ANXA1
type: EnsemblDatabaseReference

MMP15
type: EnsemblDatabaseReference

HELZ2
type: EnsemblDatabaseReference

RFTN1
type: EnsemblDatabaseReference

EIF2AK2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.11455658611719
p value: 1.67961417307962E-8
refers to: EIF2AK2

SSH3
type: EnsemblDatabaseReference

ST8SIA6-AS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 2.59339356204311E-4
refers to: ST8SIA6-AS1

TUBA4A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.74243644783119
p value: 9.94878015459899E-18
refers to: TUBA4A

FCRLA DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.9432367637106
p value: 0.00337423181300483
refers to: FCRLA

RP11-328N19.1
type: EnsemblDatabaseReference

DACH1
type: EnsemblDatabaseReference

HDHD3
type: EnsemblDatabaseReference

AXL
type: EnsemblDatabaseReference

OAS3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.67259199719396
p value: 1.54286547023024E-23
refers to: OAS3

TGFA DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10039275335832
p value: 1.03270097572301E-10
refers to: TGFA

SH2D3C
type: EnsemblDatabaseReference

CHRNE
type: EnsemblDatabaseReference

SSTR2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.14669245862623
p value: 0.0419048676188117
refers to: SSTR2

PLA2G7
type: EnsemblDatabaseReference

HLA-G DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.28785974791847
p value: 2.561862318703E-5
refers to: HLA-G

TPM2
type: EnsemblDatabaseReference

MMP15
type: EnsemblDatabaseReference

CEMIP DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.57392134892187
p value: 0.00262940526687236
refers to: CEMIP

S100A12
type: EnsemblDatabaseReference

HELZ2
type: EnsemblDatabaseReference

APBA1
type: EnsemblDatabaseReference

NRN1
type: EnsemblDatabaseReference

MAGEA4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -9.36118969735811
p value: 2.52087794200694E-71
refers to: MAGEA4

GPNMB
type: EnsemblDatabaseReference

MAGEB2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.89211282242476
p value: 6.00058033963827E-54
refers to: MAGEB2

ANPEP DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.58131002846952
p value: 2.84278659707191E-32
refers to: ANPEP

MMP25
type: EnsemblDatabaseReference

PNOC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0030315967018325
refers to: PNOC

CD69 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.63586571798468
p value: 0.0220221121433001
refers to: CD69

DACH1
type: EnsemblDatabaseReference

MPO DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.75480205630893
p value: 0.0134227580374614
refers to: MPO

MAP10 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.9416695441563
p value: 0.040015963680894
refers to: MAP10

CLEC2L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.00214856498664743
refers to: CLEC2L

LGALS3BP DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.4249436768126
p value: 3.84855337554662E-27
refers to: LGALS3BP

ISLR
type: EnsemblDatabaseReference

CTD-2184D3.5
type: EnsemblDatabaseReference

IP6K3
type: EnsemblDatabaseReference

UBE2L6
type: EnsemblDatabaseReference

PLA2G7
type: EnsemblDatabaseReference

LINC00886
type: EnsemblDatabaseReference

ANPEP
type: EnsemblDatabaseReference

NCALD DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.89161884297445
p value: 3.41828990510002E-5
refers to: NCALD

NRN1
type: EnsemblDatabaseReference

AC093673.5
type: EnsemblDatabaseReference

SLC9A5
type: EnsemblDatabaseReference

RARRES3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.38853367483142
p value: 1.66928494525877E-6
refers to: RARRES3

MMP25
type: EnsemblDatabaseReference

GRIN2D
type: EnsemblDatabaseReference

EPHA3
type: EnsemblDatabaseReference

RBP4
type: EnsemblDatabaseReference

YPEL3
type: EnsemblDatabaseReference

ISLR
type: EnsemblDatabaseReference

IP6K3
type: EnsemblDatabaseReference

UBE2L6
type: EnsemblDatabaseReference

FBXO6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.12812766866936
p value: 2.50496450230505E-6
refers to: FBXO6

ZFP36L1
type: EnsemblDatabaseReference

LINC00886
type: EnsemblDatabaseReference

AC093673.5
type: EnsemblDatabaseReference

COL9A2
type: EnsemblDatabaseReference

CD163 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.46598070676569
p value: 4.43256955019266E-36
refers to: CD163

TDRD9
type: EnsemblDatabaseReference

DHX58 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.34126944433078
p value: 3.44227843944262E-15
refers to: DHX58

RP11-497G19.1
type: EnsemblDatabaseReference

IFIT5
type: EnsemblDatabaseReference

TSPAN2
type: EnsemblDatabaseReference

GRIN2D
type: EnsemblDatabaseReference

IP6K3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.37756418338881
p value: 0.00927819137004237
refers to: IP6K3

RIN3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23450796717267
p value: 3.43010103244437E-4
refers to: RIN3

IFI44
type: EnsemblDatabaseReference

STAG3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.45501907296584
p value: 3.87357552688596E-13
refers to: STAG3

YPEL3
type: EnsemblDatabaseReference

DMD
type: EnsemblDatabaseReference

CD86 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.83565547869828
p value: 2.19704107379293E-30
refers to: CD86

CD244
type: EnsemblDatabaseReference

MPEG1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.24501287183061
p value: 1.18565697564377E-23
refers to: MPEG1

IRF6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.61230289888738
p value: 0.0126394580977573
refers to: IRF6

HIST1H4I
type: EnsemblDatabaseReference

DAZL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 2.53372464457175E-8
refers to: DAZL

PCOLCE
type: EnsemblDatabaseReference

ZFP36L1
type: EnsemblDatabaseReference

PDZRN3
type: EnsemblDatabaseReference

IFI35
type: EnsemblDatabaseReference

ENO2
type: EnsemblDatabaseReference

GAL
type: EnsemblDatabaseReference

RPS24P17
type: EnsemblDatabaseReference

TLR6
type: EnsemblDatabaseReference

COL9A2
type: EnsemblDatabaseReference

TDRD9
type: EnsemblDatabaseReference

C1orf228 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.32610414962947
p value: 4.47690877642915E-11
refers to: C1orf228

IFIT5
type: EnsemblDatabaseReference

LEKR1
type: EnsemblDatabaseReference

KHDRBS3
type: EnsemblDatabaseReference

TNFSF13B
type: EnsemblDatabaseReference

PCOLCE DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.86418536023327
p value: 1.553956794569E-20
refers to: PCOLCE

DMD
type: EnsemblDatabaseReference

NAGS DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.70795079588752
p value: 0.0104640376464951
refers to: NAGS

WNT7B
type: EnsemblDatabaseReference

RP11-10A14.5
type: EnsemblDatabaseReference

HIST1H4I
type: EnsemblDatabaseReference

IFI35
type: EnsemblDatabaseReference

ENO2
type: EnsemblDatabaseReference

GAL
type: EnsemblDatabaseReference

PHLDA1
type: EnsemblDatabaseReference

CLU
type: EnsemblDatabaseReference

ERG UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.61817026298069
p value: 1.25177930079694E-11
refers to: ERG

TLR6
type: EnsemblDatabaseReference

SLC46A3
type: EnsemblDatabaseReference

C15orf52
type: EnsemblDatabaseReference

LEKR1
type: EnsemblDatabaseReference

KHDRBS3
type: EnsemblDatabaseReference

TNFSF13B
type: EnsemblDatabaseReference

IFI6
type: EnsemblDatabaseReference

HERC6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.31698439409912
p value: 1.6914305704851E-26
refers to: HERC6

WNT7B
type: EnsemblDatabaseReference

FAM50B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10901562823659
p value: 5.74029926158673E-4
refers to: FAM50B

MAGEB1
type: EnsemblDatabaseReference

EVPL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.11602051245679
p value: 1.84129546630218E-5
refers to: EVPL

DCAF4L1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.72483803685527
p value: 3.89592818869868E-62
refers to: DCAF4L1

RP11-10A14.5
type: EnsemblDatabaseReference

PHLDA1
type: EnsemblDatabaseReference

PRL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.24422603524112
p value: 5.21684283543106E-13
refers to: PRL

TNNC1
type: EnsemblDatabaseReference

MAGEB2
type: EnsemblDatabaseReference

ACAP1
type: EnsemblDatabaseReference

NPFFR2
type: EnsemblDatabaseReference

HSPA7 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.73005571128393
p value: 1.47702104097576E-6
refers to: HSPA7

NMRK1
type: EnsemblDatabaseReference

DNM3OS
type: EnsemblDatabaseReference

CMPK2
type: EnsemblDatabaseReference

CTD-2357A8.3
type: EnsemblDatabaseReference

RP11-1220K2.2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.54109099136499
p value: 2.81314831485362E-5
refers to: RP11-1220K2.2

CNRIP1
type: EnsemblDatabaseReference

SLC46A3
type: EnsemblDatabaseReference

Homo sapiens
type: OBI_0100026

C15orf52
type: EnsemblDatabaseReference

PVRL4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.30495756456092
p value: 6.12701788606674E-8
refers to: PVRL4

RCOR2
type: EnsemblDatabaseReference

IFI6
type: EnsemblDatabaseReference

MYO1B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.80015719446969
p value: 2.08767875594059E-10
refers to: MYO1B

LSP1
type: EnsemblDatabaseReference

CPED1
type: EnsemblDatabaseReference

GBP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.99448955746638
p value: 2.74648792215328E-6
refers to: GBP1

KLHL6
type: EnsemblDatabaseReference

KRT8 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.33766756952626
p value: 0.00104702357695968
refers to: KRT8

TNNC1
type: EnsemblDatabaseReference

MAGEB2
type: EnsemblDatabaseReference

HLA-C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.48745511589844
p value: 1.37957146585671E-93
refers to: HLA-C

TRAF5
type: EnsemblDatabaseReference

DNM3OS
type: EnsemblDatabaseReference

IFI44L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.06228988052538
p value: 2.0281290758943E-31
refers to: IFI44L

CTD-2357A8.3
type: EnsemblDatabaseReference

CNRIP1
type: EnsemblDatabaseReference

OAS1
type: EnsemblDatabaseReference

ITPR3
type: EnsemblDatabaseReference

CALD1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.34751911871785
p value: 0.00240073446897016
refers to: CALD1

ATP8A1
type: EnsemblDatabaseReference

PSMB9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.41041912418495
p value: 1.45239432407797E-46
refers to: PSMB9

CPED1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.25299150734996
p value: 7.48104578686777E-11
refers to: CPED1

LSP1
type: EnsemblDatabaseReference

U82695.5 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -7.62302602325458
p value: 1.28020723897943E-33
refers to: U82695.5

PARP10
type: EnsemblDatabaseReference

SLITRK6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0449662598145016
refers to: SLITRK6

SLAMF1
type: EnsemblDatabaseReference

RLTPR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.59156994992955
p value: 2.50496450230505E-6
refers to: RLTPR

HLA-DMB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.19823390762987
p value: 0.00334814719063664
refers to: HLA-DMB

CD300A
type: EnsemblDatabaseReference

KLHL6
type: EnsemblDatabaseReference

NR5A1
type: EnsemblDatabaseReference

TRAF5
type: EnsemblDatabaseReference

IFI6 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.70941944481638
p value: 2.86275278795899E-15
refers to: IFI6

ITPR3
type: EnsemblDatabaseReference

ELFN1
type: EnsemblDatabaseReference

ATP8A1
type: EnsemblDatabaseReference

PTGFR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.33377845753794
p value: 1.32305536809701E-8
refers to: PTGFR

MLLT3
type: EnsemblDatabaseReference

CCDC152 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.35549856885482
p value: 1.90206087581092E-44
refers to: CCDC152

SDC1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.24224025220373
p value: 0.00376914123596153
refers to: SDC1

CES1P1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.6753639269493
p value: 0.0442131203785801
refers to: CES1P1

SLAMF1
type: EnsemblDatabaseReference

PRICKLE2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.26532302728635
p value: 4.66295934724443E-4
refers to: PRICKLE2

TRIB2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.12817165366369
p value: 1.25486788358493E-17
refers to: TRIB2

CD209
type: EnsemblDatabaseReference

SPHK1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.33653983528799
p value: 1.39355025988348E-5
refers to: SPHK1

HIST1H1C DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.19594316747793
p value: 0.00397016870354212
refers to: HIST1H1C

GLIS3
type: EnsemblDatabaseReference

ELFN1
type: EnsemblDatabaseReference

PNMA5
type: EnsemblDatabaseReference

RSAD2
type: EnsemblDatabaseReference

CCNA1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.19557120877886
p value: 9.77666718239487E-17
refers to: CCNA1

KIF13A DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.62944342702239
p value: 0.0330814514537065
refers to: KIF13A

MX1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.86834998116148
p value: 5.21338729971901E-59
refers to: MX1

ODF3B
type: EnsemblDatabaseReference

MLLT3
type: EnsemblDatabaseReference

MAP10
type: EnsemblDatabaseReference

COL1A2
type: EnsemblDatabaseReference

CD209
type: EnsemblDatabaseReference

SMG1P4 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 4.8153504024042
p value: 0.0376270117190434
refers to: SMG1P4

PROSER2-AS1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.76398291259039
p value: 1.17249455054376E-4
refers to: PROSER2-AS1

EOMES
type: EnsemblDatabaseReference

ISG15 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.87289315611206
p value: 6.43539171218409E-23
refers to: ISG15

GLI3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.82485523410939
p value: 0.00177722308941839
refers to: GLI3

FGD2
type: EnsemblDatabaseReference

SLC12A3
type: EnsemblDatabaseReference

PNMA5
type: EnsemblDatabaseReference

SLPI
type: EnsemblDatabaseReference

BAIAP3
type: EnsemblDatabaseReference

ODF3B
type: EnsemblDatabaseReference

FILIP1L
type: EnsemblDatabaseReference

CKB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.04899982058684
p value: 5.05985507654411E-9
refers to: CKB

CMPK2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23295179840895
p value: 3.60184445522973E-53
refers to: CMPK2

RHPN2
type: EnsemblDatabaseReference

CES1P1
type: EnsemblDatabaseReference

MIR210HG DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.31460545659393
p value: 4.55005237746024E-4
refers to: MIR210HG

TBX15 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.63802343616436
p value: 0.0171405724123143
refers to: TBX15

ITPR3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.1843378044118
p value: 3.19422681528492E-12
refers to: ITPR3

CDH10
type: EnsemblDatabaseReference

FGD2
type: EnsemblDatabaseReference

ICAM3
type: EnsemblDatabaseReference

RP11-36D19.9 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.65195614220138
p value: 2.39991505946021E-5
refers to: RP11-36D19.9

INHBA DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23738550533192
p value: 0.00334332725120488
refers to: INHBA

DNAH8
type: EnsemblDatabaseReference

SLPI
type: EnsemblDatabaseReference

BAIAP3
type: EnsemblDatabaseReference

FILIP1L
type: EnsemblDatabaseReference

RTN4RL1
type: EnsemblDatabaseReference

HR
type: EnsemblDatabaseReference

SLFN5
type: EnsemblDatabaseReference

HERC6
type: EnsemblDatabaseReference

CAMK2B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.40091397797886
p value: 0.0372671284691518
refers to: CAMK2B

MAGEA4
type: EnsemblDatabaseReference

PLXDC2
type: EnsemblDatabaseReference

IFITM3
type: EnsemblDatabaseReference

GPR126 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0274341401071929
refers to: GPR126

ISG15
type: EnsemblDatabaseReference

RHPN2
type: EnsemblDatabaseReference

DLX5
type: EnsemblDatabaseReference

PKIB
type: EnsemblDatabaseReference

PTGER2
type: EnsemblDatabaseReference

PPIC
type: EnsemblDatabaseReference

ICAM3
type: EnsemblDatabaseReference

SPARC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.49457935593625
p value: 6.38644144288968E-13
refers to: SPARC

ZNF205 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.84358906579568
p value: 5.72623021209683E-8
refers to: ZNF205

CD226
type: EnsemblDatabaseReference

DNAH8
type: EnsemblDatabaseReference

RTN4RL1
type: EnsemblDatabaseReference

HR
type: EnsemblDatabaseReference

GPR114 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.56924528845573
p value: 1.54453597201564E-7
refers to: GPR114

ULBP2
type: EnsemblDatabaseReference

CREB5
type: EnsemblDatabaseReference

TMEM169
type: EnsemblDatabaseReference

HLA-H
type: EnsemblDatabaseReference

MAGEA4
type: EnsemblDatabaseReference

IFITM3
type: EnsemblDatabaseReference

SULF2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.24538716955568
p value: 4.29748171996874E-25
refers to: SULF2

ISG15
type: EnsemblDatabaseReference

PRAM1
type: EnsemblDatabaseReference

HIST1H3H DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.85871421740208
p value: 0.00856806979935966
refers to: HIST1H3H

DLX5
type: EnsemblDatabaseReference

LRRC18 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.6255320727152
p value: 0.00216202942585041
refers to: LRRC18

TNR DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.64784844518913
p value: 0.0121495855352038
refers to: TNR

HSPA1A
type: EnsemblDatabaseReference

PTGER2
type: EnsemblDatabaseReference

GATA2
type: EnsemblDatabaseReference

OTOF DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.00178126633007264
refers to: OTOF

PPIC
type: EnsemblDatabaseReference

CHRNE DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -4.48707514126821
p value: 0.00467883256412544
refers to: CHRNE

LL22NC03-N14H11.1
type: EnsemblDatabaseReference

KCNK13 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.63796751696825
p value: 1.19963765091139E-25
refers to: KCNK13

ANTXR2
type: EnsemblDatabaseReference

ULBP2
type: EnsemblDatabaseReference

CREB5
type: EnsemblDatabaseReference

HLA-H
type: EnsemblDatabaseReference

HCRTR2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.39406009124272
p value: 0.0013581125911067
refers to: HCRTR2

EFNB2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.39056541048097
p value: 0.00611763367321551
refers to: EFNB2

TBX3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.43381818820816
p value: 0.0117554417098585
refers to: TBX3

PRAM1
type: EnsemblDatabaseReference

SPP1
type: EnsemblDatabaseReference

MPO
type: EnsemblDatabaseReference

ACAP1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10884345051125
p value: 0.0305122863107326
refers to: ACAP1

HSPA1A
type: EnsemblDatabaseReference

TCN1
type: EnsemblDatabaseReference

CTHRC1
type: EnsemblDatabaseReference

TAP1
type: EnsemblDatabaseReference

PI15 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.64013029736514
p value: 1.33483656547331E-6
refers to: PI15

MYO7A
type: EnsemblDatabaseReference

FAM71E1
type: EnsemblDatabaseReference

C10orf10
type: EnsemblDatabaseReference

ALOX5
type: EnsemblDatabaseReference

DTX4
type: EnsemblDatabaseReference

MFAP2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0292843012013197
refers to: MFAP2

BARX1
type: EnsemblDatabaseReference

DDX10P1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.19826957009
p value: 0.003839120912179
refers to: DDX10P1

RP11-153M7.3
type: EnsemblDatabaseReference

IFI44L
type: EnsemblDatabaseReference

PRAME DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -6.56922048080773
p value: 1.86213112941308E-77
refers to: PRAME

MPO
type: EnsemblDatabaseReference

SPP1
type: EnsemblDatabaseReference

H19
type: EnsemblDatabaseReference

RP11-47A8.5
type: EnsemblDatabaseReference

TAP1
type: EnsemblDatabaseReference

MB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.88899442257271
p value: 0.00466214304809934
refers to: MB

FAM111B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.73562738822612
p value: 2.66579679385796E-4
refers to: FAM111B

ARG2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.74751108333138
p value: 1.31212027733252E-6
refers to: ARG2

RP11-497G19.2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -5.08125718633489
p value: 2.02565089615997E-5
refers to: RP11-497G19.2

FAM71E1
type: EnsemblDatabaseReference

MSRB3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.75039174981619
p value: 1.22119103470349E-12
refers to: MSRB3

WNT7B DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.18613607900954
p value: 0.0242085653058156
refers to: WNT7B

AFAP1
type: EnsemblDatabaseReference

KIAA0040
type: EnsemblDatabaseReference

RP11-320G10.1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.24252109760047
p value: 0.00551266636879138
refers to: RP11-320G10.1

FAUP1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.984931505077
p value: 3.21136170109862E-6
refers to: FAUP1

EVPL
type: EnsemblDatabaseReference

TYMP DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.29665022668724
p value: 6.47072049503343E-30
refers to: TYMP

HSD3B7 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.44634130040518
p value: 0.0246769730848654
refers to: HSD3B7

DTX4
type: EnsemblDatabaseReference

KHDRBS2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.50654771726139
p value: 0.0153976637449087
refers to: KHDRBS2

BARX1
type: EnsemblDatabaseReference

RP11-153M7.3
type: EnsemblDatabaseReference

AURKC DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.3638857251564
p value: 3.74619130021284E-4
refers to: AURKC

MKRN4P DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.29391394618583
p value: 0.00274292939629378
refers to: MKRN4P

SLPI DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.67446152714491
p value: 2.83866701505265E-19
refers to: SLPI

H19
type: EnsemblDatabaseReference

NCF2
type: EnsemblDatabaseReference

ABTB2
type: EnsemblDatabaseReference

UNC5CL DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.67055663207129
p value: 0.00480805652497289
refers to: UNC5CL

DSC2
type: EnsemblDatabaseReference

PTCHD3P2 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -Infinity
p value: 0.0139658900116653
refers to: PTCHD3P2

ROPN1L
type: EnsemblDatabaseReference

NPAS1 UP in 'azacytidine' vs 'untreated'
type: IncreasedDifferentialExpressionRatio
fold change: 1.62480534751065
p value: 4.02715980978319E-10
refers to: NPAS1

DUXAP8 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.53373801246673
p value: 6.78618361664747E-7
refers to: DUXAP8

AFAP1
type: EnsemblDatabaseReference

KIAA0040
type: EnsemblDatabaseReference

ITGA3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.947137317039
p value: 1.87691014872984E-6
refers to: ITGA3

FSTL1 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -3.1414921822212
p value: 1.43404127305069E-5
refers to: FSTL1

EGR3
type: EnsemblDatabaseReference

MAOB DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.94872196469881
p value: 1.44331303936795E-4
refers to: MAOB

AC110781.3
type: EnsemblDatabaseReference

VWCE
type: EnsemblDatabaseReference

NCF2
type: EnsemblDatabaseReference

SLC46A3 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.50160881362364
p value: 7.4144485928563E-5
refers to: SLC46A3

ZEB1
type: EnsemblDatabaseReference

ROPN1L
type: EnsemblDatabaseReference

RP11-330A16.1
type: EnsemblDatabaseReference

KIAA1244
type: EnsemblDatabaseReference

ZNF302
type: EnsemblDatabaseReference

XKR9 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.84936246196109
p value: 1.00910328570605E-5
refers to: XKR9

RP3-395M20.8
type: EnsemblDatabaseReference

STRA6
type: EnsemblDatabaseReference

MB
type: EnsemblDatabaseReference

RARRES3
type: EnsemblDatabaseReference

HIST2H2BF
type: EnsemblDatabaseReference

PTGFR
type: EnsemblDatabaseReference

AC110781.3
type: EnsemblDatabaseReference

PTGS2
type: EnsemblDatabaseReference

DDX60
type: EnsemblDatabaseReference

CLGN
type: EnsemblDatabaseReference

RBBP8P1
type: EnsemblDatabaseReference

CKB
type: EnsemblDatabaseReference

NDUFA4L2
type: EnsemblDatabaseReference

ZEB1
type: EnsemblDatabaseReference

KIAA1244
type: EnsemblDatabaseReference

IER5L DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -2.93392562467135
p value: 0.023462222241448
refers to: IER5L

(Assay) SRR1171523
type: Assay

RP3-395M20.8
type: EnsemblDatabaseReference

MB
type: EnsemblDatabaseReference

RARRES3
type: EnsemblDatabaseReference

HIST2H2BF
type: EnsemblDatabaseReference

PNLDC1
type: EnsemblDatabaseReference

CLEC2L
type: EnsemblDatabaseReference

SSTR2
type: EnsemblDatabaseReference

DDX10P1
type: EnsemblDatabaseReference

COL4A4 DOWN in 'azacytidine' vs 'untreated'
type: DecreasedDifferentialExpressionRatio
fold change: -1.9077543122123
p value: 0.0029050128211837
refers to: COL4A4

ARHGAP20
type: EnsemblDatabaseReference